<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5142774</article-id><article-id pub-id-type="pmid">27926925</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0005194</article-id><article-id pub-id-type="publisher-id">PNTD-D-16-00557</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>West Nile virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>West Nile virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>West Nile virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Flaviviruses</subject><subj-group><subject>West Nile virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Immunologic Techniques</subject><subj-group><subject>Immunoassays</subject><subj-group><subject>Enzyme-Linked Immunoassays</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Vector-Borne Diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>Pakistan</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Sudan</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Serology</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Dengue in the Middle East and North Africa: A Systematic Review</article-title><alt-title alt-title-type="running-head">Dengue in the MENA</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Humphrey</surname><given-names>John M.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Cleton</surname><given-names>Natalie B.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Reusken</surname><given-names>Chantal B. E. M.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Glesby</surname><given-names>Marshall J.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Koopmans</surname><given-names>Marion P. G.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abu-Raddad</surname><given-names>Laith J.</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, New York, United States of America</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Erasmus Medical Centre, Rotterdam, The Netherlands</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>National Institute for Public Health and Environment (RIVM), Bilthoven, The Netherlands</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Healthcare Policy and Research, Weill Cornell Medical College, Cornell University, New York, New York, United States of America</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Infectious Disease Epidemiology Group, Weill Cornell Medical College in Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>College of Public Health, Hamad bin Khalifa University, Qatar Foundation, Education City, Doha, Qatar</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Horstick</surname><given-names>Olaf</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Heidelberg, GERMANY</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p><list list-type="simple"><list-item><p><bold>Conceptualization:</bold> JMH NBC CBEMR MPGK LJAR.</p></list-item><list-item><p><bold>Formal analysis:</bold> JMH LJAR.</p></list-item><list-item><p><bold>Investigation:</bold> JMH NBC.</p></list-item><list-item><p><bold>Methodology:</bold> MJG MPGK LJAR.</p></list-item><list-item><p><bold>Software:</bold> LJAR.</p></list-item><list-item><p><bold>Supervision:</bold> MJG CBEMR MPGK LJAR.</p></list-item><list-item><p><bold>Writing &#x02013; original draft:</bold> JMH.</p></list-item></list>
</p></fn><corresp id="cor001">* E-mail: <email>john.m.humphrey@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>7</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2016</year></pub-date><volume>10</volume><issue>12</issue><elocation-id>e0005194</elocation-id><history><date date-type="received"><day>25</day><month>3</month><year>2016</year></date><date date-type="accepted"><day>17</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Humphrey et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Humphrey et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pntd.0005194.pdf"/><abstract><sec id="sec001"><title>Background</title><p>Dengue virus (DENV) infection is widespread and its disease burden has increased in past decades. However, little is known about the epidemiology of dengue in the Middle East and North Africa (MENA).</p></sec><sec id="sec002"><title>Methodology / Principal Findings</title><p>Following Cochrane Collaboration guidelines and reporting our findings following PRISMA guidelines, we systematically reviewed available records across MENA describing dengue occurrence in humans (prevalence studies, incidence studies, and outbreak reports), occurrence of suitable vectors (<italic>Aedes aegypti</italic> and <italic>Aedes albopictus)</italic>, and DENV vector infection rates. We identified 105 human prevalence measures in 13 of 24 MENA countries; 81 outbreaks reported from 9 countries from 1941&#x02013;2015; and reports of <italic>Ae</italic>. <italic>aegypti</italic> and/or <italic>Ae</italic>. <italic>albopictus</italic> occurrence in 15 countries. The majority of seroprevalence studies were reported from the Red Sea region and Pakistan, with multiple studies indicating &#x0003e;20% DENV seroprevalence in general populations (median 25%, range 0&#x02013;62%) in these subregions. Fifty percent of these studies were conducted prior to 1990. Multiple studies utilized assays susceptible to serologic cross-reactions and 5% of seroprevalence studies utilized viral neutralization testing. There was considerable heterogeneity in study design and outbreak reporting, as well as variability in subregional study coverage, study populations, and laboratory methods used for diagnosis.</p></sec><sec id="sec003"><title>Conclusions / Significance</title><p>DENV seroprevalence in the MENA is high among some populations in the Red Sea region and Pakistan, while recent outbreaks in these subregions suggest increasing incidence of DENV which may be driven by a variety of ecologic and social factors. However, there is insufficient study coverage to draw conclusions about <italic>Aedes</italic> or DENV presence in multiple MENA countries. These findings illustrate the epidemiology of DENV in the MENA while revealing priorities for DENV surveillance and <italic>Aedes</italic> control.</p></sec></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Dengue is a mosquito-transmitted flavivirus whose global distribution and disease incidence has increased in recent decades. In the Middle East and North Africa, the epidemiology of dengue remains poorly characterized despite increasing reports of outbreaks and transmission in new areas. In order to understand the evidence supporting the epidemiology of this virus in the region and the areas in need of further research, we conducted a systematic review of studies reporting human prevalence, incidence, and infection rates in the virus&#x02019; main mosquito vectors, <italic>Aedes aegypti</italic> and <italic>Aedes albopictus</italic>. Among the studies identified, the Red Sea subregion and Pakistan reported the highest seroprevalence estimates for dengue. However, we encountered substantial heterogeneity in the distribution, quality, and quantity of published studies. These findings inform future research and surveillance priorities for DENV in the MENA region.</p></abstract><funding-group><funding-statement>This publication was made possible by support provided by the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar. JMH received support from NIH Research Training Grant T32 AI007613. The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="6"/><page-count count="31"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec004"><title>Introduction</title><p>Dengue virus (DENV) is a globally distributed flavivirus with nearly 400 million estimated annual infections and a growing geographic distribution and disease burden [<xref rid="pntd.0005194.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pntd.0005194.ref003" ref-type="bibr">3</xref>]. DENV has a historic presence in the Middle East and North Africa (MENA), with outbreaks of dengue and dengue-like disease reported across much of the Eastern Mediterranean region in the 19<sup>th</sup> and early 20<sup>th</sup> centuries [<xref rid="pntd.0005194.ref004" ref-type="bibr">4</xref>, <xref rid="pntd.0005194.ref005" ref-type="bibr">5</xref>]. Today, DENV may be resurging in the MENA [<xref rid="pntd.0005194.ref006" ref-type="bibr">6</xref>, <xref rid="pntd.0005194.ref007" ref-type="bibr">7</xref>], with recent outbreaks of unprecedented or previously unrecognized magnitude occurring in the Arabian Peninsula and Pakistan [<xref rid="pntd.0005194.ref008" ref-type="bibr">8</xref>, <xref rid="pntd.0005194.ref009" ref-type="bibr">9</xref>], and a 2015 outbreak in Egypt that occurred following a decades-long absence of reported cases from that country [<xref rid="pntd.0005194.ref010" ref-type="bibr">10</xref>]. Still, despite increasing global concern about the threat of <italic>Aedes</italic>-transmitted arboviruses, the epidemiology of DENV in the MENA region remains largely uncharacterized.</p><p>Understanding the epidemiology of DENV in the MENA represents an ongoing challenge for multiple reasons [<xref rid="pntd.0005194.ref011" ref-type="bibr">11</xref>]. Inadequate human and vector surveillance, non-reporting of illness syndromes, and poor diagnostic capacity limit DENV detection in many countries, resulting in delays in outbreak recognition and sparse data with which to estimate disease burden and infection rates [<xref rid="pntd.0005194.ref012" ref-type="bibr">12</xref>&#x02013;<xref rid="pntd.0005194.ref014" ref-type="bibr">14</xref>]. Case series, outbreak reports, and national notification reports, which contribute much to the epidemiologic knowledge of DENV, may also contain bias in reflecting only those areas with sufficient capacity to detect and report DENV when it occurs [<xref rid="pntd.0005194.ref001" ref-type="bibr">1</xref>]. Moreover, clinical diagnosis of DENV infection in the absence of laboratory confirmation is often unreliable [<xref rid="pntd.0005194.ref012" ref-type="bibr">12</xref>, <xref rid="pntd.0005194.ref015" ref-type="bibr">15</xref>&#x02013;<xref rid="pntd.0005194.ref018" ref-type="bibr">18</xref>]. Cross-sectional serologic surveys for DENV exposure have the potential to shed light on the broader population burden of DENV without these biases. However, serologic cross-reactions among antibody-based assays for flaviviruses can limit the reliability of such studies in the absence of confirmatory testing, though the latter is difficult to perform and often unavailable [<xref rid="pntd.0005194.ref019" ref-type="bibr">19</xref>, <xref rid="pntd.0005194.ref020" ref-type="bibr">20</xref>].</p><p>To further the knowledge of the epidemiology of DENV in the MENA, we undertook a comprehensive summary and appraisal of published DENV prevalence, incidence, vector infection rates, reported outbreaks, and <italic>Aedes</italic> occurrence reports in the MENA region. This report aims to enhance the understanding of the epidemiology of DENV in the MENA while informing priorities for future research.</p></sec><sec sec-type="materials|methods" id="sec005"><title>Materials and Methods</title><sec id="sec006"><title>Objectives</title><p>The objective of this study was to characterize the epidemiology of DENV in the MENA region through a systematic review of human prevalence and incidence studies and infection rates in <italic>Aedes</italic> mosquitoes. We also aimed to summarize reported human outbreaks and <italic>Ae</italic>. <italic>aegypti and Ae</italic>. <italic>albopictus</italic> occurrence in the region. The original search was last updated on December 9, 2015.</p></sec><sec id="sec007"><title>Eligibility criteria</title><p><xref rid="pntd.0005194.t001" ref-type="table">Table 1</xref> displays the eligibility criteria. In brief, studies containing primary prevalence, incidence, and vector infection rates for DENV in the MENA region were considered eligible for the systematic review. Publication year was not considered an inclusion criterion, as we reasoned that the historic distribution of DENV could be useful in understanding its current epidemiology by depicting ecologically viable regions in which DENV transmission continues to occur or could re-emerge. For incidence studies, those that reported the number of acute infections or seroconversions over any time interval were eligible. Vector infection rate studies were included if they contained a measure of the estimated proportion of infected <italic>Ae</italic>. <italic>aegypti</italic> or <italic>Ae</italic>. <italic>albopictus</italic> at a given time and setting in the MENA region.</p><table-wrap id="pntd.0005194.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.t001</object-id><label>Table 1</label><caption><title>Criteria for study inclusion or exclusion.</title></caption><alternatives><graphic id="pntd.0005194.t001g" xlink:href="pntd.0005194.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Study type</bold></th><th align="left" rowspan="1" colspan="1"><bold>Inclusion Criteria</bold></th><th align="left" rowspan="1" colspan="1"><bold>Exclusion Criteria</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Human prevalence/incidence</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;publication characteristics</td><td align="left" rowspan="1" colspan="1">Full article or abstract published in any year, language, setting, or population in the MENA region; any seroconversion interval for incidence studies</td><td align="left" rowspan="1" colspan="1">Case reports, case series, editorials, letters to editors, reviews, commentaries, qualitative studies, basic science research studies, studies from countries outside the MENA region</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;study design</td><td align="left" rowspan="1" colspan="1">Any randomized or non-randomized design</td><td align="left" rowspan="1" colspan="1">Non-empirical research/modelled data</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;outcomes</td><td align="left" rowspan="1" colspan="1">DENV seroprevalence or prevalence of laboratory-confirmed infection; DENV incidence (by any laboratory method)</td><td align="left" rowspan="1" colspan="1">No human prevalence or incidence measure reported</td></tr><tr><td align="left" rowspan="1" colspan="1">Vector infection rate</td><td align="left" rowspan="1" colspan="1">Reported <italic>Ae</italic>. <italic>aegypti</italic> or <italic>Ae</italic>. <italic>albopictus</italic> infection rates by any laboratory method</td><td align="left" rowspan="1" colspan="1">Basic science research studies, infection rates in other mosquito species or non-MENA country</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec008"><title>Outcomes</title><p>For the systematic review, the primary outcomes were DENV human prevalence, incidence, and vector infection rates in the MENA region. Secondary outcomes were reports of dengue outbreaks and vector occurrence.</p></sec><sec id="sec009"><title>Data sources and search strategy</title><p>We conducted a systematic search for DENV in the MENA following Cochrane Collaboration guidelines [<xref rid="pntd.0005194.ref021" ref-type="bibr">21</xref>] and reported our findings using the Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) guidelines [<xref rid="pntd.0005194.ref022" ref-type="bibr">22</xref>]. The PRISMA checklist is found in <xref ref-type="supplementary-material" rid="pntd.0005194.s001">S1 Fig</xref> and our search criteria in <xref ref-type="supplementary-material" rid="pntd.0005194.s002">S2 Fig</xref>. Briefly, we searched PubMed, Embase, the World Health Organization (WHO) Index Medicus for the Eastern Mediterranean Region and WHO African Index Medicus without publication date or language restrictions, using text and MeSH/Emtree terms exploded to include all subheadings. Our review covered the 23 countries included in the MENA definitions of the WHO/EMRO, World Bank, and the Joint United Nations Programme on HIV/AIDS (UNAIDS) for consistency with earlier regional analyses of various infectious diseases including HIV [<xref rid="pntd.0005194.ref023" ref-type="bibr">23</xref>].</p></sec><sec id="sec010"><title>Study selection</title><p>For each search, titles and abstracts were imported into Endnote (Thompson Reuters, Philadelphia, PA, USA), duplicates were removed, and were screened by one author (JH) with potential eligibility determined by consensus with a second author (NC) when eligibility was unclear. Full texts of potentially relevant records were retrieved and assessed for eligibility, contacting the author of the report as necessary. Reference lists of all potentially eligible articles and reviews were also searched. In this study, &#x02018;report&#x02019; refers to the document (paper, abstract, or public health record) containing an outcome measure of interest, while &#x02018;study&#x02019; refers to the outcome measure(s) within that report. Hence, reports could contribute more than one study, though multiple reports of the same study were counted only once.</p></sec><sec id="sec011"><title>Data Extraction and Synthesis</title><p>Data were extracted by one of the authors (JH) using a pre-piloted data extraction form and entered into a database created in Microsoft Access. Data from reports in English were extracted from the full texts, while reports in French (n = 6), Turkish (n = 3), Dutch (n = 1), and German (n = 1) were extracted from the abstracts and full texts with the help of online language software and French, Turkish, and German language speakers [<xref rid="pntd.0005194.ref024" ref-type="bibr">24</xref>]. There were no records in other languages. Studies were compiled by country and organized by year, using separate tables for human prevalence, incidence, and vector infection rates. Prevalence studies were further stratified as follows: 1) <italic>general prevalence studies</italic> measuring the prevalence of anti-DENV antibodies among populations without acute infection (e.g. DENV exposure); and 2) <italic>acute DENV infection studies</italic> assessing the prevalence of laboratory-confirmed DENV infection in those with a) undifferentiated acute febrile illness (AFI) and b) suspected DENV infection (<xref rid="pntd.0005194.t002" ref-type="table">Table 2</xref>). These stratifications were made because of the different study aims and probabilities of having laboratory evidence of DENV infection in each of these populations. Finally, the geographic distribution of all included prevalence studies were mapped according to the first-level administrative division (e.g. state, province) in which each study was conducted (Tableau Software, Seattle, WA, USA).</p><table-wrap id="pntd.0005194.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.t002</object-id><label>Table 2</label><caption><title>Definitions of human prevalence study populations identified through the systematic review.</title></caption><alternatives><graphic id="pntd.0005194.t002g" xlink:href="pntd.0005194.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Study Population</bold></th><th align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>Definition</bold></th></tr></thead><tbody><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">General prevalence</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Seroprevalence studies reporting anti-DENV IgG prevalence measures among individuals not suspected to have acute dengue infection, including community members, blood donors, military, students, and hospitalized patients and outpatients receiving care for non-febrile illnesses.</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Acute DENV infection</td><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold><italic>Undifferentiated acute febrile illness (AFI)</italic></bold>: studies for which acute dengue infection is not differentiated by clinical grounds alone; IgG prevalence measures obtained during the acute phase of illness is these studies are presumed to reflect secondary infection.</td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"/><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold><italic>Suspected dengue infection</italic></bold>: studies in which defined or undefined clinical criteria for probable dengue infection is stated as an inclusion criterion in the study.</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec012"><title>Risk of bias assessment</title><p>In order to gain a better understanding of the quality of prevalence studies identified through the systematic review, the risk of bias (ROB) was assessed for each study based on the Cochrane approach [<xref rid="pntd.0005194.ref025" ref-type="bibr">25</xref>] and by evaluating the precision of the reported measures. The methodology for this assessment is similar to that which we have previously developed for reviews of HIV and hepatitis C prevalence in the MENA region [<xref rid="pntd.0005194.ref026" ref-type="bibr">26</xref>&#x02013;<xref rid="pntd.0005194.ref028" ref-type="bibr">28</xref>]. Each DENV prevalence measure was considered to have a low, high, or unclear ROB in three domains: sampling methodology, DENV infection ascertainment, and response rate. The latter was defined as the number of tested individuals divided by the number of persons invited to participate in the study [<xref rid="pntd.0005194.ref029" ref-type="bibr">29</xref>]. ROB was considered low if (1) sampling was probability-based (i.e. using some form of random selection), (2) DENV prevalence measures included viral neutralization testing (VNT) for general prevalence studies or biological assays (i.e. cell culture, PCR, and NS1 ELISA) for acute infection studies, and (3) response rate was &#x02265;80%. Studies with missing information for any of the domains were classified as having unclear ROB for that specific domain. Sampling strategy was not evaluated for acute infection studies because these studies enrolled individuals presenting to a health facility with acute infection, hence, no population-based sampling is needed to capture this population. Studies were considered to have high precision if the number of individuals tested was &#x02265; 100. We considered this to be a reasonably sensitive cutoff for precision given the heterogeneous epidemiology of DENV across the region (e.g. a prevalence of 1% entails a 95% CI of 0&#x02013;3%).</p></sec><sec id="sec013"><title>DENV outbreaks and <italic>Aedes</italic> distribution</title><p>To supplement the epidemiologic data gathered through the systematic search, reported outbreaks and <italic>Ae</italic>. <italic>aegypti</italic> or <italic>Ae</italic>. <italic>albopictus</italic> occurrence in the MENA were also sought from the articles retrieved through the search databases as well as through ProMED-MENA and Google Scholar. Given that the characteristics and definitions of dengue outbreaks in the literature are implicitly variable and that there is currently no consensus on how to define such events [<xref rid="pntd.0005194.ref030" ref-type="bibr">30</xref>], we broadly included any outbreak report if the author of the report defined the event as an outbreak. Multiple reports of the same outbreak were recorded only once. We manually marked the location of reported outbreaks on the map as well, designating one mark per each first-level administrative division in which one or more outbreaks were identified. In a separate map, we mapped the country-level occurrence of <italic>Ae</italic>. <italic>aegypti</italic> and <italic>Ae</italic>. <italic>albopictus</italic> in order to further inform the existing or potential epidemiology of DENV in the MENA.</p></sec></sec><sec sec-type="results" id="sec014"><title>Results</title><sec id="sec015"><title>Search results</title><p>The selection process based on PRISMA guidelines is illustrated in <xref ref-type="fig" rid="pntd.0005194.g001">Fig 1</xref> [<xref rid="pntd.0005194.ref022" ref-type="bibr">22</xref>]. Briefly, the DENV search yielded 1,258 citations, 91 of which were ultimately eligible for inclusion in the study following the addition of 4 reports identified from the bibliographies of relevant reports and reviews. Four studies from the 1970-80s were excluded that contained DENV seroprevalence of 0&#x02013;11% in wild and domestic animals in Pakistan, Tunisia, and Turkey, though these may have represented cross-reactions with other flaviviruses [<xref rid="pntd.0005194.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="pntd.0005194.ref034" ref-type="bibr">34</xref>].</p><fig id="pntd.0005194.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.g001</object-id><label>Fig 1</label><caption><title>PRISMA flow diagram of article selection.</title><p>Flow diagram for dengue prevalence, incidence, and vector infection rates in the Middle East and North Africa.</p></caption><graphic xlink:href="pntd.0005194.g001"/></fig></sec><sec id="sec016"><title>Characteristics of included studies</title><p>A total of 105 human prevalence studies for DENV were identified from eligible reports (<xref rid="pntd.0005194.t003" ref-type="table">Table 3</xref>). These studies covered 13 of 24 MENA countries and were conducted from 1962&#x02013;2015. The geographic distribution of these studies is illustrated in <xref ref-type="fig" rid="pntd.0005194.g002">Fig 2</xref>, and <xref rid="pntd.0005194.t004" ref-type="table">Table 4</xref> contains a frequency summary of these studies. Anti-DENV antibodies were detected in 12 of 13 countries in which studies were reported with a single 1973 study from Libya reporting 0% seroprevalence [<xref rid="pntd.0005194.ref035" ref-type="bibr">35</xref>]. The highest number of studies were reported from Pakistan (n = 32) and Sudan (n = 16), most of which targeted populations with acute DENV infection (undifferentiated AFI or suspected dengue infection). Among general population studies, IgG prevalence measures ranged from 0% to 61% and were reported from Djibouti (n = 4, 0&#x02013;21%), Egypt (n = 4, 0&#x02013;7%), Iran (n = 3, 0&#x02013;7%), Kuwait (n = 3, 0&#x02013;56%), Lebanon (n = 3, 0&#x02013;61%), Pakistan (n = 3, 9&#x02013;28%), Saudi Arabia (n = 4, 0&#x02013;33%), and Sudan (n = 5, 9&#x02013;49%). ELISAs were the most commonly used diagnostic method for all study types and the majority studies from the MENA used in-house assays (<xref rid="pntd.0005194.t004" ref-type="table">Table 4</xref>). VNT results were reported in 3% (n = 3) of all studies while observed or potential serologic cross-reactions with other flaviviruses were present in multiple studies [<xref rid="pntd.0005194.ref036" ref-type="bibr">36</xref>&#x02013;<xref rid="pntd.0005194.ref038" ref-type="bibr">38</xref>] (Tables <xref rid="pntd.0005194.t003" ref-type="table">3</xref> and <xref rid="pntd.0005194.t004" ref-type="table">4</xref>). Three human incidence measures for DENV were identified (<xref rid="pntd.0005194.t005" ref-type="table">Table 5</xref>): the first reported an ELISA IgM incidence of 35 cases per 10,000 people living in urban homes in Port Sudan City, Sudan where DENV-carrying mosquitoes were identified over an 11-month period [<xref rid="pntd.0005194.ref039" ref-type="bibr">39</xref>]; the second reported an ELISA IgM incidence of 94 cases per 10,000 people in a general population in Port Sudan, Sudan over a 17-week period in 2010 [<xref rid="pntd.0005194.ref040" ref-type="bibr">40</xref>]; the third reported an ELISA IgM, NS1 antigen, or PCR incidence of 185 cases per 100,000 febrile children in an urban slum in Karachi, Pakistan from 1999&#x02013;2001 [<xref rid="pntd.0005194.ref041" ref-type="bibr">41</xref>]. Three vector infection rate studies for <italic>Ae</italic>. <italic>aegypti</italic> and <italic>Ae</italic>. <italic>albopictus</italic> were identified from Pakistan and Yemen [<xref rid="pntd.0005194.ref042" ref-type="bibr">42</xref>, <xref rid="pntd.0005194.ref043" ref-type="bibr">43</xref>] (<xref rid="pntd.0005194.t006" ref-type="table">Table 6</xref>).</p><fig id="pntd.0005194.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.g002</object-id><label>Fig 2</label><caption><title>Geographic distribution of human prevalence studies and reported outbreaks of dengue in the Middle East and North Africa.</title></caption><graphic xlink:href="pntd.0005194.g002"/></fig><table-wrap id="pntd.0005194.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.t003</object-id><label>Table 3</label><caption><title>Human prevalence studies for dengue virus in the Middle East and North Africa (n = 105).</title></caption><alternatives><graphic id="pntd.0005194.t003g" xlink:href="pntd.0005194.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Country, Ref.</th><th align="center" rowspan="1" colspan="1">Year(s) of study<xref ref-type="table-fn" rid="t003fn001">*</xref></th><th align="center" rowspan="1" colspan="1">City or governorate</th><th align="center" rowspan="1" colspan="1">Setting; population (age range, years)</th><th align="center" rowspan="1" colspan="1">Sampling</th><th align="center" rowspan="1" colspan="1">Assay type</th><th align="center" rowspan="1" colspan="1">Assay make<xref ref-type="table-fn" rid="t003fn002"><sup>&#x02020;</sup></xref></th><th align="center" rowspan="1" colspan="1">Target Protein</th><th align="center" rowspan="1" colspan="1">Assay serotype</th><th align="center" rowspan="1" colspan="1">Sample size</th><th align="center" rowspan="1" colspan="1">Prevalence</th><th align="center" rowspan="1" colspan="1">Additional testing&#x00026; Comments</th></tr></thead><tbody><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Afghanistan</bold> (n = 1)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Elyan [<xref rid="pntd.0005194.ref044" ref-type="bibr">44</xref>]</td><td align="center" rowspan="1" colspan="1">2008&#x02013;10</td><td align="center" rowspan="1" colspan="1">Uruzgon, Helmand, Kandahar</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients (20&#x02013;59)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">913</td><td align="center" rowspan="1" colspan="1"><bold>19.2%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">2.6% (8/312) were IgM+; observed cross-reaction to WNV, TBEV</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Djibouti</bold> (n = 6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Salah [<xref rid="pntd.0005194.ref045" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1">1987</td><td align="center" rowspan="1" colspan="1">Djibouti City</td><td align="center" rowspan="1" colspan="1">Military; healthy soldiers</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IIFA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Randa</td><td align="center" rowspan="1" colspan="1">Rural community; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IIFA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Djibouti City</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IIFA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Rodier [<xref rid="pntd.0005194.ref037" ref-type="bibr">37</xref>]</td><td align="center" rowspan="1" colspan="1">1991</td><td align="center" rowspan="1" colspan="1">Djibouti City</td><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients (1&#x02013;55)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">91</td><td align="center" rowspan="1" colspan="1"><bold>7.7%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">3.7% (1/27) were VNT+; multiple observed cross-reactions</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>25.2%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">11.1% (3/27) were VNT+; multiple observed cross-reactions</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>16.4%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">multiple observed cross-reactions</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>18.7%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">multiple observed cross-reactions</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Fauld [<xref rid="pntd.0005194.ref046" ref-type="bibr">46</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Djibouti City</td><td align="center" rowspan="1" colspan="1">Animal quarantine station; workers</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IIFA</td><td align="center" rowspan="1" colspan="1">EuroImmun</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1"><bold>10.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">not cross-reactive to WNV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Andayi [<xref rid="pntd.0005194.ref047" ref-type="bibr">47</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" rowspan="1" colspan="1">Djibouti City</td><td align="center" rowspan="1" colspan="1">Community; general pop. (&#x0003c;1&#x02013;100)</td><td align="center" rowspan="1" colspan="1">SRS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">911</td><td align="center" rowspan="1" colspan="1"><bold>21.8%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Egypt</bold> (n = 5)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Mohammed [<xref rid="pntd.0005194.ref048" ref-type="bibr">48</xref>]</td><td align="center" rowspan="1" colspan="1">1966</td><td align="center" rowspan="1" colspan="1">Abyss</td><td align="center" rowspan="1" colspan="1">rural community; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1"><bold>7.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">possible cross-reaction to WNV</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>3.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">possible cross-reaction to WNV</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Alexandria</td><td align="center" rowspan="1" colspan="1">urban community; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1"><bold>4.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">possible cross-reaction to WNV</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>5.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">possible cross-reaction to WNV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Mohammed [<xref rid="pntd.0005194.ref049" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1">1968</td><td align="center" rowspan="1" colspan="1">Alexandria</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients (3&#x02013;13)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI, CF</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">120</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">0% (0/48) were convalescent +</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Alexandria</td><td align="center" rowspan="1" colspan="1">Clinical setting; adults</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">78</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Darwish [<xref rid="pntd.0005194.ref050" ref-type="bibr">50</xref>]</td><td align="center" rowspan="1" colspan="1">1969</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">University; students</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1133</td><td align="center" rowspan="1" colspan="1"><bold>0.3%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Iran</bold> (n = 4)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Saidi [<xref rid="pntd.0005194.ref051" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">1970</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1,2,3</td><td align="center" rowspan="1" colspan="1">394</td><td align="center" rowspan="1" colspan="1"><bold>6.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">possible cross-reaction to WNV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Saidi [<xref rid="pntd.0005194.ref052" ref-type="bibr">52</xref>]</td><td align="center" rowspan="1" colspan="1">1970&#x02013;71</td><td align="center" rowspan="1" colspan="1">Caspian region</td><td align="center" rowspan="1" colspan="1">Community; children (1&#x02013;6)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Chinikar [<xref rid="pntd.0005194.ref053" ref-type="bibr">53</xref>]</td><td align="center" rowspan="1" colspan="1">2000&#x02013;12</td><td align="center" rowspan="1" colspan="1">Countrywide</td><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Vircell</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1,2</td><td align="center" rowspan="1" colspan="1">300</td><td align="center" rowspan="1" colspan="1"><bold>3.3%</bold></td><td align="center" rowspan="1" colspan="1">3.3% (10/300) were IgM+; DEN-1,2 were positive by PCR</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Aghaie [<xref rid="pntd.0005194.ref014" ref-type="bibr">14</xref>]</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">Sistan-Baluchestan</td><td align="center" rowspan="1" colspan="1">blood donor center; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">540</td><td align="center" rowspan="1" colspan="1"><bold>7.6%</bold></td><td align="center" rowspan="1" colspan="1">78% (32/41) ELISA+ were IFA+</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Kuwait</bold> (n = 8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ibrahim [<xref rid="pntd.0005194.ref054" ref-type="bibr">54</xref>]</td><td align="center" rowspan="1" colspan="1">1966&#x02013;68</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">Multiple settings; blood donors, non-AFI patients, children (1&#x02013;60)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">627</td><td align="center" rowspan="1" colspan="1"><bold>6.5%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">not cross-reactive to DEN-2 or WNV</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>8.1%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">not cross-reactive to DEN-1 or WNV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Al-Nakib [<xref rid="pntd.0005194.ref055" ref-type="bibr">55</xref>]</td><td align="center" rowspan="1" colspan="1">1979&#x02013;82</td><td align="center" rowspan="1" colspan="1">Jabriya</td><td align="center" rowspan="1" colspan="1">Hospital; non-AFI patients (0&#x02013;60+)</td><td align="center" rowspan="1" colspan="1">SRS</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">502</td><td align="center" rowspan="1" colspan="1"><bold>3.2%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">not cross-reactive to DEN-2 or WNV</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>8.4%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">all were cross-reactive to DEN-1, WNV, or TBEV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Pacsa [<xref rid="pntd.0005194.ref056" ref-type="bibr">56</xref>]</td><td align="center" rowspan="1" colspan="1">2002<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">n/s; Kuwaiti nationals</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">ELISA and IgG blot</td><td align="center" rowspan="1" colspan="1">CDC and Genlab</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">425</td><td align="center" rowspan="1" colspan="1"><bold>13.9%</bold></td><td align="center" rowspan="1" colspan="1">only DENV 1&#x02013;3 were positive</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">n/s; Kuwait Bedouins</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">ELISA and IgG blot</td><td align="center" rowspan="1" colspan="1">CDC and Genlab</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">n/s; expatriates from South Asia</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">ELISA and IgG blot</td><td align="center" rowspan="1" colspan="1">CDC and Genlab</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">266</td><td align="center" rowspan="1" colspan="1"><bold>37%</bold></td><td align="center" rowspan="1" colspan="1">only DENV 1&#x02013;3 were positive</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">n/s; expatriates from Southeast Asia</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">ELISA and IgG blot</td><td align="center" rowspan="1" colspan="1">CDC and Genlab</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1"><bold>56.6%</bold></td><td align="center" rowspan="1" colspan="1">only DENV 1&#x02013;3 were positive</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">n/s; expatriates from Middle East</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">ELISA and IgG blot</td><td align="center" rowspan="1" colspan="1">CDC and Genlab</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">140</td><td align="center" rowspan="1" colspan="1"><bold>25%</bold></td><td align="center" rowspan="1" colspan="1">only DENV 1&#x02013;3 were positive</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Hospital; returned travelers with dengue-like illness</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">210</td><td align="center" rowspan="1" colspan="1"><bold>9.0%</bold></td><td align="center" rowspan="1" colspan="1">only DENV 1&#x02013;3 were positive; 10%(2/19) IgM+ were PCR+</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Lebanon</bold> (n = 3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Garabedian [<xref rid="pntd.0005194.ref005" ref-type="bibr">5</xref>]</td><td align="center" rowspan="1" colspan="1">1962&#x02013;65</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">Community; general pop. (0&#x02013;41+)</td><td align="center" rowspan="1" colspan="1">SRS</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">113</td><td align="center" rowspan="1" colspan="1"><bold>61.9%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">observed cross-reaction with WNV, YFV</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">Community; general pop. (0&#x02013;41+)</td><td align="center" rowspan="1" colspan="1">SRS</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">171</td><td align="center" rowspan="1" colspan="1"><bold>49.1%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">observed cross-reaction with WNV, YFV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Hatem [<xref rid="pntd.0005194.ref057" ref-type="bibr">57</xref>]</td><td align="center" rowspan="1" colspan="1">1969</td><td align="center" rowspan="1" colspan="1">Beirut</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">126</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>4.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">observed cross-reaction with WNV</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Libya</bold> (n = 1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Darwish [<xref rid="pntd.0005194.ref035" ref-type="bibr">35</xref>]</td><td align="center" rowspan="1" colspan="1">1973</td><td align="center" rowspan="1" colspan="1">Sebha</td><td align="center" rowspan="1" colspan="1">community and clinic; children, non-AFI patients</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">148</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Pakistan</bold> (n = 32)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Darwish [<xref rid="pntd.0005194.ref031" ref-type="bibr">31</xref>]</td><td align="center" rowspan="1" colspan="1">1983<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; patients</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">CF</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">43</td><td align="center" rowspan="1" colspan="1"><bold>9.3%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Akram [<xref rid="pntd.0005194.ref058" ref-type="bibr">58</xref>]</td><td align="center" rowspan="1" colspan="1">1994</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients (&#x0003c;1&#x02013;12)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1"><bold>9.8%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">12% (3/25) additional convalescent sera were +; observed cross-reaction to WNV</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1"><italic>Same</italic></td><td align="center" rowspan="1" colspan="1"><bold>14.6%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">24% (6/25) additional convalescent sera were +; observed cross-reaction to WNV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Siddiqui [<xref rid="pntd.0005194.ref041" ref-type="bibr">41</xref>]</td><td align="center" rowspan="1" colspan="1">1999&#x02013;2001</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Community; AFI patients (&#x0003c;16)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">Diag. Auto.</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">341</td><td align="center" rowspan="1" colspan="1"><bold>15.8%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Tariq [<xref rid="pntd.0005194.ref059" ref-type="bibr">59</xref>]</td><td align="center" rowspan="1" colspan="1">2003</td><td align="center" rowspan="1" colspan="1">Mangla, Mirpur</td><td align="center" rowspan="1" colspan="1">Community; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1"><bold>73%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Jamil [<xref rid="pntd.0005194.ref060" ref-type="bibr">60</xref>]</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospitals; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">Chemicon</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">106</td><td align="center" rowspan="1" colspan="1"><bold>36.8%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Khan [<xref rid="pntd.0005194.ref061" ref-type="bibr">61</xref>]</td><td align="center" rowspan="1" colspan="1">2006</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (2&#x02013;72)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">83</td><td align="center" rowspan="1" colspan="1"><bold>83.6%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Conv</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">Calbiotech</td><td align="center" rowspan="1" colspan="1">PA</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1"><italic>same</italic></td><td align="center" rowspan="1" colspan="1"><bold>50.7%</bold></td><td align="center" rowspan="1" colspan="1">87.8% (73/83) were PCR+ for DEN-2,3 only</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Khan [<xref rid="pntd.0005194.ref062" ref-type="bibr">62</xref>]</td><td align="center" rowspan="1" colspan="1">2006</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">250</td><td align="center" rowspan="1" colspan="1"><bold>23.2%</bold></td><td align="center" rowspan="1" colspan="1">53.6% (134/250) were IgM+; 74% (185/250) were PCR+ for DEN-2 or 3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Koo [<xref rid="pntd.0005194.ref063" ref-type="bibr">63</xref>]</td><td align="center" rowspan="1" colspan="1">2006&#x02013;11</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">Clinic settings; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">PCR</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">2,3</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1"><bold>47%</bold></td><td align="center" rowspan="1" colspan="1">none were DEN-1 positive</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Khan [<xref rid="pntd.0005194.ref064" ref-type="bibr">64</xref>]</td><td align="center" rowspan="1" colspan="1">2006&#x02013;07</td><td align="center" rowspan="1" colspan="1">Hyderabad</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (13&#x02013;70)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1"><bold>40%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Khan [<xref rid="pntd.0005194.ref065" ref-type="bibr">65</xref>]</td><td align="center" rowspan="1" colspan="1">2006&#x02013;07</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">Calbiotech</td><td align="center" rowspan="1" colspan="1">PA</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">15,040</td><td align="center" rowspan="1" colspan="1"><bold>26.3%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Abbasi [<xref rid="pntd.0005194.ref066" ref-type="bibr">66</xref>]</td><td align="center" rowspan="1" colspan="1">2007&#x02013;08</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">Commercial</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">114</td><td align="center" rowspan="1" colspan="1"><bold>69.6%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Tahir [<xref rid="pntd.0005194.ref067" ref-type="bibr">67</xref>]</td><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ICT (IgM)</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">3215</td><td align="center" rowspan="1" colspan="1"><bold>54.9%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Murad [<xref rid="pntd.0005194.ref068" ref-type="bibr">68</xref>]</td><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">Shangla</td><td align="center" rowspan="1" colspan="1">Community; suspected dengue (1&#x02013;80)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">70</td><td align="center" rowspan="1" colspan="1"><bold>17.1%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mahmood [<xref rid="pntd.0005194.ref069" ref-type="bibr">69</xref>]</td><td align="center" rowspan="1" colspan="1">2008</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue secondary infection (age 1&#x02013;80)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">NovaLisa</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">200</td><td align="center" rowspan="1" colspan="1"><bold>39.5%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue primary infection (age 1&#x02013;80)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">DRG</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">341</td><td align="center" rowspan="1" colspan="1"><bold>48.7%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Kidwai [<xref rid="pntd.0005194.ref070" ref-type="bibr">70</xref>]</td><td align="center" rowspan="1" colspan="1">2008&#x02013;09</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (&#x0003e;13)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ICT (IgG)</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">599</td><td align="center" rowspan="1" colspan="1"><bold>83.2%</bold></td><td align="center" rowspan="1" colspan="1">41.9% (251/599) were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">Zafar [<xref rid="pntd.0005194.ref071" ref-type="bibr">71</xref>]</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">Rawalpindi</td><td align="center" rowspan="1" colspan="1">rural communities; adults without history of flavivirus vaccination (&#x0003e;18)</td><td align="center" rowspan="1" colspan="1">StRS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Omega</td><td align="center" rowspan="1" colspan="1">PA (DEN-2)</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1"><bold>19.8%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Zafar [<xref rid="pntd.0005194.ref072" ref-type="bibr">72</xref>]</td><td align="center" rowspan="1" colspan="1">2009</td><td align="center" rowspan="1" colspan="1">Rawalpindi</td><td align="center" rowspan="1" colspan="1">Community; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Omega,Vircell</td><td align="center" rowspan="1" colspan="1">PA (DEN-2)</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">244</td><td align="center" rowspan="1" colspan="1"><bold>28.8%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Qureshi [<xref rid="pntd.0005194.ref073" ref-type="bibr">73</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;12</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ICT (IgM)</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">162</td><td align="center" rowspan="1" colspan="1"><bold>9.9%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Khan [<xref rid="pntd.0005194.ref074" ref-type="bibr">74</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Punjab</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (4&#x02013;60)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">125</td><td align="center" rowspan="1" colspan="1"><bold>54.4%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Hasan [<xref rid="pntd.0005194.ref075" ref-type="bibr">75</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (&#x0003e;12)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">259</td><td align="center" rowspan="1" colspan="1"><bold>34.8%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Umar [<xref rid="pntd.0005194.ref076" ref-type="bibr">76</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Rawalpindi</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">500</td><td align="center" rowspan="1" colspan="1"><bold>6.8%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Jameel [<xref rid="pntd.0005194.ref077" ref-type="bibr">77</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">341</td><td align="center" rowspan="1" colspan="1"><bold>48.7%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Naeem [<xref rid="pntd.0005194.ref078" ref-type="bibr">78</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (1&#x02013;10+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">79</td><td align="center" rowspan="1" colspan="1"><bold>25.3%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ahmed [<xref rid="pntd.0005194.ref079" ref-type="bibr">79</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (13&#x02013;81)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">640</td><td align="center" rowspan="1" colspan="1"><bold>43.9%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ijaz [<xref rid="pntd.0005194.ref080" ref-type="bibr">80</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (&#x0003c;15&#x02013;60+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">5,274</td><td align="center" rowspan="1" colspan="1"><bold>49%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Rashid [<xref rid="pntd.0005194.ref081" ref-type="bibr">81</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (&#x0003c;18)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">254</td><td align="center" rowspan="1" colspan="1"><bold>36.6%</bold></td><td align="center" rowspan="1" colspan="1">53.9% (137/254) were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Khan [<xref rid="pntd.0005194.ref082" ref-type="bibr">82</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (5&#x02013;50+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">50</td><td align="center" rowspan="1" colspan="1"><bold>72%</bold></td><td align="center" rowspan="1" colspan="1">30% (30/50) were IgM+; 66% (33/50) were PCR+ for DEN-1,2; 60% (30/50) were cell culture+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Hasan [<xref rid="pntd.0005194.ref083" ref-type="bibr">83</xref>]</td><td align="center" rowspan="1" colspan="1">2007&#x02013;13</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">Hospitals; suspected Crimean-Congo Hemorrhagic Fever</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">168</td><td align="center" rowspan="1" colspan="1"><bold>33.9%</bold></td><td align="center" rowspan="1" colspan="1">2.3% (4/168) were PCR+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ali [<xref rid="pntd.0005194.ref084" ref-type="bibr">84</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Khyber Pakhtunkhwa</td><td align="center" rowspan="1" colspan="1">Clinical settings; suspected dengue (&#x0003c;10 to &#x0003e;51)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Diag. Auto.</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">612</td><td align="center" rowspan="1" colspan="1"><bold>20.2%</bold></td><td align="center" rowspan="1" colspan="1">31.9% (195/612) were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Hisam [<xref rid="pntd.0005194.ref085" ref-type="bibr">85</xref>]</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">Rawalpindi</td><td align="center" rowspan="1" colspan="1">Military Hospital; AFI patients</td><td align="center" rowspan="1" colspan="1">PS</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">500</td><td align="center" rowspan="1" colspan="1"><bold>3.2%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Assir [<xref rid="pntd.0005194.ref086" ref-type="bibr">86</xref>]</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (12&#x02013;90)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">GmbH</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">85</td><td align="center" rowspan="1" colspan="1"><bold>43.5%</bold></td><td align="center" rowspan="1" colspan="1">20% (3/15) were PCR + for DEN-2</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Saudi Arabia</bold> (n = 11)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Fakeeh [<xref rid="pntd.0005194.ref087" ref-type="bibr">87</xref>]</td><td align="center" rowspan="1" colspan="1">1994&#x02013;99</td><td align="center" rowspan="1" colspan="1">Jeddah</td><td align="center" rowspan="1" colspan="1">Hospitals; suspected dengue (1-&#x0003e;50)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IIFA, HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1,2</td><td align="center" rowspan="1" colspan="1">985</td><td align="center" rowspan="1" colspan="1"><bold>31.9%</bold></td><td align="center" rowspan="1" colspan="1">16.2% (160/985) were ELISA IgM+; 21% (207/985) were PCR+ (DEN-1,2,3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Fakeeh [<xref rid="pntd.0005194.ref088" ref-type="bibr">88</xref>]</td><td align="center" rowspan="1" colspan="1">1994&#x02013;2002</td><td align="center" rowspan="1" colspan="1">Jeddah</td><td align="center" rowspan="1" colspan="1">Hospitals; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">IFA, HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1,2,3</td><td align="center" rowspan="1" colspan="1">1020</td><td align="center" rowspan="1" colspan="1"><bold>50.5%</bold></td><td align="center" rowspan="1" colspan="1">10.8% (110/1020) were ELISA IgM+; 20.5% (209/1020) were PCR+ (DEN-1,2,3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Khan [<xref rid="pntd.0005194.ref089" ref-type="bibr">89</xref>]</td><td align="center" rowspan="1" colspan="1">2004</td><td align="center" rowspan="1" colspan="1">Makkah</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (6&#x02013;94)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">136</td><td align="center" rowspan="1" colspan="1"><bold>32.4%</bold></td><td align="center" rowspan="1" colspan="1">58.8% (80/136) were IgM+; 28.1% (27/96) were PCR + (DEN-2,3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ayyub [<xref rid="pntd.0005194.ref090" ref-type="bibr">90</xref>]</td><td align="center" rowspan="1" colspan="1">2004&#x02013;05</td><td align="center" rowspan="1" colspan="1">Jeddah</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (2&#x02013;60)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1"><bold>48.8%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Shahin [<xref rid="pntd.0005194.ref091" ref-type="bibr">91</xref>]</td><td align="center" rowspan="1" colspan="1">2006&#x02013;08</td><td align="center" rowspan="1" colspan="1">Makkah</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM and/or PCR</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">159</td><td align="center" rowspan="1" colspan="1"><bold>100%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Said [<xref rid="pntd.0005194.ref092" ref-type="bibr">92</xref>]</td><td align="center" rowspan="1" colspan="1">2006</td><td align="center" rowspan="1" colspan="1">Jeddah</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (2&#x02013;71)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">525</td><td align="center" rowspan="1" colspan="1"><bold>19.2%</bold></td><td align="center" rowspan="1" colspan="1">% includes paired serum sample</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Memish [<xref rid="pntd.0005194.ref093" ref-type="bibr">93</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Multiple</td><td align="center" rowspan="1" colspan="1">Military; adults</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">1024</td><td align="center" rowspan="1" colspan="1"><bold>0.1%</bold></td><td align="center" rowspan="1" colspan="1">0% of IgG+ were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Gamil [<xref rid="pntd.0005194.ref094" ref-type="bibr">94</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" rowspan="1" colspan="1">Jeddah</td><td align="center" rowspan="1" colspan="1">Hospitals; suspected dengue (3&#x02013;56)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">553</td><td align="center" rowspan="1" colspan="1"><bold>47.7%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Al-Azraqi [<xref rid="pntd.0005194.ref095" ref-type="bibr">95</xref>]</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">Jizan</td><td align="center" rowspan="1" colspan="1">Clinics; clinic attendants (1&#x02013;60+)</td><td align="center" rowspan="1" colspan="1">SRS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Focus</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">268</td><td align="center" rowspan="1" colspan="1"><bold>26.5%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Aseer</td><td align="center" rowspan="1" colspan="1">Clinics; clinic attendants (1&#x02013;60+)</td><td align="center" rowspan="1" colspan="1">SRS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Focus</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">697</td><td align="center" rowspan="1" colspan="1"><bold>33.7%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ashshi [<xref rid="pntd.0005194.ref096" ref-type="bibr">96</xref>]</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">Mecca</td><td align="center" rowspan="1" colspan="1">blood donation center; adults</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1"><bold>7%</bold></td><td align="center" rowspan="1" colspan="1">6% (6/100) were IgM+;1% (1/100) were NS1+</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Somalia</bold> (n = 7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Botros [<xref rid="pntd.0005194.ref097" ref-type="bibr">97</xref>]</td><td align="center" rowspan="1" colspan="1">1987</td><td align="center" rowspan="1" colspan="1">Hargeysa</td><td align="center" rowspan="1" colspan="1">Refugee camp; AFI patients</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1"><bold>60.7%</bold></td><td align="center" rowspan="1" colspan="1">acute and convalescent samples; 39.4% (15/38) were IFA+; 37.9% (11/29) were HI+; 14.2% (4/28) were ELISA IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">Kanesa-thasan [<xref rid="pntd.0005194.ref098" ref-type="bibr">98</xref>]</td><td align="center" rowspan="1" colspan="1">1993</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">Military base; AFI soldiers</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM and/or HI</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">84</td><td align="center" rowspan="1" colspan="1"><bold>17.8%</bold></td><td align="center" rowspan="1" colspan="1">93% (14/15) were cell culture + (DEN-2 and 3 only)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Sharp [<xref rid="pntd.0005194.ref099" ref-type="bibr">99</xref>]</td><td align="center" rowspan="1" colspan="1">1992&#x02013;93</td><td align="center" rowspan="1" colspan="1">Mogadishu</td><td align="center" rowspan="1" colspan="1">Military Hospital; AFI patients (soldiers)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">129</td><td align="center" rowspan="1" colspan="1"><bold>34.9%</bold></td><td align="center" rowspan="1" colspan="1">40.6% (39/96) were cell culture positive for DEN-2; 2% (2/96) were cell culture positive for DEN-3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Baardera</td><td align="center" rowspan="1" colspan="1">Military; adults (19&#x02013;25)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">494</td><td align="center" rowspan="1" colspan="1"><bold>7.7%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">observed cross-reaction with WNV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Nur [<xref rid="pntd.0005194.ref100" ref-type="bibr">100</xref>]</td><td align="center" rowspan="1" colspan="1">1995</td><td align="center" rowspan="1" colspan="1">Mogadishu</td><td align="center" rowspan="1" colspan="1">Hospital; children (&#x0003c;1 to &#x0003e; 2 years of age)</td><td align="center" rowspan="1" colspan="1">CC.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">Progen</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Hospital; AFI patients with / without rash (&#x0003c;1 to &#x0003e; 2 years of age)</td><td align="center" rowspan="1" colspan="1">CC.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">Progen</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Kyobe Bosa [<xref rid="pntd.0005194.ref101" ref-type="bibr">101</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Mogadishu</td><td align="center" rowspan="1" colspan="1">Hospitals; AFI patients (20&#x02013;49)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">1,2,3</td><td align="center" rowspan="1" colspan="1">134</td><td align="center" rowspan="1" colspan="1"><bold>80%</bold></td><td align="center" rowspan="1" colspan="1">62% (83/134) were PCR+</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Sudan</bold> (n = 16)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Omer [<xref rid="pntd.0005194.ref036" ref-type="bibr">36</xref>]</td><td align="center" rowspan="1" colspan="1">1976</td><td align="center" rowspan="1" colspan="1">Gezira</td><td align="center" rowspan="1" colspan="1">Rural community; general pop. (5&#x02013;40+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">109</td><td align="center" rowspan="1" colspan="1"><bold>27.5%</bold></td><td align="center" rowspan="1" colspan="1">17.4% (19/109) were VNT+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Hyams [<xref rid="pntd.0005194.ref102" ref-type="bibr">102</xref>]</td><td align="center" rowspan="1" colspan="1">1984</td><td align="center" rowspan="1" colspan="1">Port Sudan</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients (12&#x02013;70)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1"><bold>3%</bold></td><td align="center" rowspan="1" colspan="1">14.8% (8/54) were convalescent +; 1% (1/100) DEN-1 cell culture +; 17% (17/100) DEN-2 cell culture +</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Woodruff [<xref rid="pntd.0005194.ref103" ref-type="bibr">103</xref>]</td><td align="center" rowspan="1" colspan="1">1986</td><td align="center" rowspan="1" colspan="1">Juba</td><td align="center" rowspan="1" colspan="1">Hospital; patients with history of fever within past 6 months and AFI patients (1&#x02013;85)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">130</td><td align="center" rowspan="1" colspan="1"><bold>40.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">represents single virus activity not cross-reactive to multiple flaviviruses tested</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;McCarthy [<xref rid="pntd.0005194.ref104" ref-type="bibr">104</xref>]</td><td align="center" rowspan="1" colspan="1">1988</td><td align="center" rowspan="1" colspan="1">Khartoum</td><td align="center" rowspan="1" colspan="1">Clinical setting; non-AFI patients</td><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1"><bold>49%</bold></td><td align="center" rowspan="1" colspan="1">0% were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients (1&#x02013;89)</td><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">196</td><td align="center" rowspan="1" colspan="1"><bold>48%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">0% were IgM+; possible cross-reaction to WNV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Watts [<xref rid="pntd.0005194.ref018" ref-type="bibr">18</xref>]</td><td align="center" rowspan="1" colspan="1">1989</td><td align="center" rowspan="1" colspan="1">Northern Province</td><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients (11&#x02013;70)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">185</td><td align="center" rowspan="1" colspan="1"><bold>24.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">possible cross-reactions to multiple flaviviruses</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ibrahim [<xref rid="pntd.0005194.ref105" ref-type="bibr">105</xref>]</td><td align="center" rowspan="1" colspan="1">1997&#x02013;99</td><td align="center" rowspan="1" colspan="1">Khartoum</td><td align="center" rowspan="1" colspan="1">Clinical setting: suspected measles</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">MRL Diag.</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">188</td><td align="center" rowspan="1" colspan="1"><bold>3.2%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Malik [<xref rid="pntd.0005194.ref106" ref-type="bibr">106</xref>]</td><td align="center" rowspan="1" colspan="1">2004&#x02013;05</td><td align="center" rowspan="1" colspan="1">Port Sudan</td><td align="center" rowspan="1" colspan="1">Hospitals; suspected dengue (&#x0003c;1&#x02013;15)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">40</td><td align="center" rowspan="1" colspan="1"><bold>90.0%</bold></td><td align="center" rowspan="1" colspan="1">39% (9/23) were PCR+ (DEN-3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Gould [<xref rid="pntd.0005194.ref107" ref-type="bibr">107</xref>]</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">South Kordofan</td><td align="center" rowspan="1" colspan="1">Clinical setting; suspected YF patients (n = 3), severe illness (n = 8), AFI patients (n = 7), healthy (n = 16)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1"><bold>5.9%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">observed cross-reaction with YFV, WNV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Farnon [<xref rid="pntd.0005194.ref038" ref-type="bibr">38</xref>]</td><td align="center" rowspan="1" colspan="1">2005</td><td align="center" rowspan="1" colspan="1">Kortalla</td><td align="center" rowspan="1" colspan="1">Community; general pop., YF vaccinated (0&#x02013;44+)</td><td align="center" rowspan="1" colspan="1">SSCS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">87</td><td align="center" rowspan="1" colspan="1"><bold>1.1%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">observed cross-reaction in YF vaccine recipient; 0% were IgM+; 52% (45/87) were VNT+ for DENV and YFV</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Seidahmed [<xref rid="pntd.0005194.ref039" ref-type="bibr">39</xref>]</td><td align="center" rowspan="1" colspan="1">2008&#x02013;09</td><td align="center" rowspan="1" colspan="1">Port Sudan City</td><td align="center" rowspan="1" colspan="1">Urban community; individuals from houses with DENV-carrying mosquitoes (&#x0003c;1&#x02013;80)</td><td align="center" rowspan="1" colspan="1">RSS</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">791</td><td align="center" rowspan="1" colspan="1"><bold>5.2%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Adam [<xref rid="pntd.0005194.ref108" ref-type="bibr">108</xref>]</td><td align="center" rowspan="1" colspan="1">2008&#x02013;09</td><td align="center" rowspan="1" colspan="1">Port Sudan City</td><td align="center" rowspan="1" colspan="1">Hospitals; pregnant women with deliveries</td><td align="center" rowspan="1" colspan="1">Ret. cohort</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">10,820</td><td align="center" rowspan="1" colspan="1"><bold>0.7%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Himatt [<xref rid="pntd.0005194.ref109" ref-type="bibr">109</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Kassala state</td><td align="center" rowspan="1" colspan="1">Community; general pop. (5&#x02013;75+)</td><td align="center" rowspan="1" colspan="1">MSCS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">489</td><td align="center" rowspan="1" colspan="1"><bold>9.4%</bold></td><td align="center" rowspan="1" colspan="1">0.6% (3/489) were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Abdalla [<xref rid="pntd.0005194.ref110" ref-type="bibr">110</xref>]</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">Kassala State</td><td align="center" rowspan="1" colspan="1">Hospital; AFI patients with suspected measles (2&#x02013;65)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">60</td><td align="center" rowspan="1" colspan="1"><bold>11.7%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Elduma [<xref rid="pntd.0005194.ref015" ref-type="bibr">15</xref>]</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">Port Sudan</td><td align="center" rowspan="1" colspan="1">Hospital; pregnant women with AFI</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Commercial</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1"><bold>12.8%</bold></td><td align="center" rowspan="1" colspan="1">2.6% (1/39) were IgM+ and PCR+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Soghaier [<xref rid="pntd.0005194.ref111" ref-type="bibr">111</xref>]</td><td align="center" rowspan="1" colspan="1">2014</td><td align="center" rowspan="1" colspan="1">South Kordofan</td><td align="center" rowspan="1" colspan="1">Urban and rural communities; general pop. (15&#x02013;60)</td><td align="center" rowspan="1" colspan="1">MSCS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">600</td><td align="center" rowspan="1" colspan="1"><bold>27.7%</bold></td><td align="center" rowspan="1" colspan="1">77% of study population were YFV vaccinated</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Turkey</bold> (n = 6)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ari [<xref rid="pntd.0005194.ref034" ref-type="bibr">34</xref>]</td><td align="center" rowspan="1" colspan="1">1971</td><td align="center" rowspan="1" colspan="1">Izmir</td><td align="center" rowspan="1" colspan="1">Community and clinic; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">270</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Radda [<xref rid="pntd.0005194.ref112" ref-type="bibr">112</xref>]</td><td align="center" rowspan="1" colspan="1">1973<xref ref-type="table-fn" rid="t003fn001">*</xref></td><td align="center" rowspan="1" colspan="1">Izmir</td><td align="center" rowspan="1" colspan="1">n/s; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">270</td><td align="center" rowspan="1" colspan="1"><bold>0.3%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">observed cross-reaction with WNV</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Istanbul</td><td align="center" rowspan="1" colspan="1">n/s; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">Ankara</td><td align="center" rowspan="1" colspan="1">n/s; general pop.</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">HI</td><td align="center" rowspan="1" colspan="1">In-house</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">95</td><td align="center" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Ergunay [<xref rid="pntd.0005194.ref113" ref-type="bibr">113</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Ankara, Konya, Eskisehir, Zonguldak</td><td align="center" rowspan="1" colspan="1">blood donation center; blood donors</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">EuroImmun</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">2435</td><td align="center" rowspan="1" colspan="1"><bold>0.9%</bold></td><td align="center" rowspan="1" colspan="1">14.2% (3/21) of IgG+ were IIFT+ for DEN-2; 9.5% (2/21) of IgG+ were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Tezcan [<xref rid="pntd.0005194.ref114" ref-type="bibr">114</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" rowspan="1" colspan="1">Mersin</td><td align="center" rowspan="1" colspan="1">blood donation center; blood donors</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">Vircell</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">920</td><td align="center" rowspan="1" colspan="1"><bold>16.6%</bold></td><td align="center" rowspan="1" colspan="1">0.9% (8/920) were IgM+; 0% were NS1+</td></tr><tr><td align="left" colspan="12" style="background-color:#D9D9D9" rowspan="1"><bold>Yemen</bold> (n = 5)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Bin Ghouth [<xref rid="pntd.0005194.ref115" ref-type="bibr">115</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Hadramout</td><td align="center" rowspan="1" colspan="1">Hospital; suspected dengue (&#x0003c;5 to 55+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">982</td><td align="center" rowspan="1" colspan="1"><bold>50.6%</bold></td><td align="center" rowspan="1" colspan="1">64.1% (630/982) IgM+; 86.2% (163/189) PCR+ for DEN-3</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Malik [<xref rid="pntd.0005194.ref116" ref-type="bibr">116</xref>]</td><td align="center" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" rowspan="1" colspan="1">Al-Hudaydah</td><td align="center" rowspan="1" colspan="1">Clinical setting; AFI patients (0&#x02013;45+)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">136</td><td align="center" rowspan="1" colspan="1"><bold>87.5%</bold></td><td align="center" rowspan="1" colspan="1">8.1% (11/136) were IgM+</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Madani [<xref rid="pntd.0005194.ref117" ref-type="bibr">117</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">Hadramout</td><td align="center" rowspan="1" colspan="1">Clinical settings; suspected viral hemorrhagic fever (3&#x02013;75)</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">207</td><td align="center" rowspan="1" colspan="1"><bold>48.3%</bold></td><td align="center" rowspan="1" colspan="1">78.7% (163/207) IgM+; 46.9% (97/207) NS1+; 0.09% (2/207) PCR+ for DEN-1,2</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Rezza [<xref rid="pntd.0005194.ref118" ref-type="bibr">118</xref>]</td><td align="center" rowspan="1" colspan="1">2012</td><td align="center" rowspan="1" colspan="1">Al Hudaydah</td><td align="center" rowspan="1" colspan="1">Hospitals; AFI patients with dengue-like illness (1&#x02013;60)</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">ELISA</td><td align="center" rowspan="1" colspan="1">NovaLisa</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">400</td><td align="center" rowspan="1" colspan="1"><bold>72.5%</bold></td><td align="center" rowspan="1" colspan="1">18% (72/400) IgM+; 13.8% (55/400) PCR+ for DEN-1,2</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;Qassem [<xref rid="pntd.0005194.ref119" ref-type="bibr">119</xref>]</td><td align="center" rowspan="1" colspan="1">2013</td><td align="center" rowspan="1" colspan="1">Hadramout</td><td align="center" rowspan="1" colspan="1">Clinical setting; suspected dengue and/or west nile infection</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">42</td><td align="center" rowspan="1" colspan="1"><bold>19.0%</bold><xref ref-type="table-fn" rid="t003fn003">**</xref></td><td align="center" rowspan="1" colspan="1">observed cross-reaction with WNV</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>* Indicates year of publication when year(s) of data collection not available in report.</p></fn><fn id="t003fn002"><p><sup><bold>&#x02020;</bold></sup> All serologic assays were IgG unless otherwise stated.</p></fn><fn id="t003fn003"><p>**Indicates documented occurrence or suspicion of false-positives due to cross-reactions with other same family viruses or low serologic titers.</p></fn><fn id="t003fn004"><p>Abbreviations: AFI, acute febrile illness patients; Ag, antigen; CF, complement fixation; Conv, convenience; ELISA, enzyme-linked immunosorbent assay; HI, hemagglutinin inhibition; ICT, immunochromatography test; IIFA, indirect immunofluorescence antibody test; MSCS, multi-stage cluster sampling; n/s, not specified; NS1, NS1 antigen test; PA, purified antigen; PCR, polymerase chain reaction; pop., population; PS, purposive sampling; RSS, random stratified sampling; SRS, simple random sampling; SSCS, single stage cluster sampling; VNT, viral neutralization test</p></fn><fn id="t003fn005"><p>Assay Abbreviation: <italic>CDC</italic> (Centers for Disease Control and Prevention, USA); <italic>Chemicon</italic> (Chemicon, Temecula, CA, USA); <italic>Diag</italic>. <italic>Auto</italic>. (Diagnostic Automation, CA, USA); <italic>DRG</italic> (DRG International Inc); <italic>Euroimmun</italic> (Lubeck, Germany); <italic>Focus</italic> (Focus Diagnostics, Cypress CA, USA); Genlab (Genlab Diagnostics, Singapore); GmbH (Human GmbH, Wiesbaden, Germany); <italic>MRL Diagnostics</italic> (Cypress CA, USA); <italic>NovaLisa</italic> (Dietzenbach, Germany); <italic>Omega</italic> (Omega Diagnostics, Scotland, UK); <italic>PanBio</italic> (Brisbane, Australia); <italic>Progen</italic> (Heidelberg, Germany); <italic>SD Bioline</italic> (Standard Diagnostics, Korea); <italic>Vircell</italic> (Vircell Microbiologists, Granada, Spain)</p></fn></table-wrap-foot></table-wrap><table-wrap id="pntd.0005194.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.t004</object-id><label>Table 4</label><caption><title>Summary of human prevalence studies for dengue virus in the Middle East and North Africa (n = 103).<xref ref-type="table-fn" rid="t004fn001">*</xref></title></caption><alternatives><graphic id="pntd.0005194.t004g" xlink:href="pntd.0005194.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Study characteristics</bold></th><th align="center" rowspan="1" colspan="1"><bold>General population (n = 42) n (%)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Acute febrile illness (n = 23) n (%)</bold></th><th align="center" rowspan="1" colspan="1"><bold>Suspected dengue (n = 38) n (%)</bold></th></tr></thead><tbody><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Total sample size</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">24,377</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">4,065</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">33,955</td></tr><tr><td align="left" rowspan="1" colspan="1">Median DENV % prevalence (range %)</td><td align="center" rowspan="1" colspan="1">25% (0&#x02013;61.9)</td><td align="center" rowspan="1" colspan="1">15.2% (0&#x02013;87.5)</td><td align="center" rowspan="1" colspan="1">47.4% (6.8&#x02013;100)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Year of study</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;before 1990</td><td align="center" rowspan="1" colspan="1">21 (50%)</td><td align="center" rowspan="1" colspan="1">7 (30%)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;1990 to 2015</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">21 (50%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">16 (70%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">38 (100%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Study setting</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;community</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">31 (74%)<xref ref-type="table-fn" rid="t004fn002"><sup><bold>&#x02020;</bold></sup></xref></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">2 (9%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">2 (5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;clinic or hospital</td><td align="center" rowspan="1" colspan="1">11 (26%)</td><td align="center" rowspan="1" colspan="1">21 (91%)</td><td align="center" rowspan="1" colspan="1">36 (95%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Assay</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;ELISA IgG</td><td align="center" rowspan="1" colspan="1">19 (45%)</td><td align="center" rowspan="1" colspan="1">8 (35%)</td><td align="center" rowspan="1" colspan="1">10 (26%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;ELISA IgM</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">11 (26%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">17 (74%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">31 (82%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;immunofluorescence antibody</td><td align="center" rowspan="1" colspan="1">5 (12%)</td><td align="center" rowspan="1" colspan="1">2 (9%)</td><td align="center" rowspan="1" colspan="1">2 (5%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;hemagglutination inhibition</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">15 (36%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">5 (22%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">2 (5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;complement fixation</td><td align="center" rowspan="1" colspan="1">1 (2%)</td><td align="center" rowspan="1" colspan="1">1 (4%)</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;viral neutralization</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">2 (5%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">1 (4%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;PCR</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">4 (17%)</td><td align="center" rowspan="1" colspan="1">14 (37%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;cell culture</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">3 (13%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">1 (3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;NS1 antigen</td><td align="center" rowspan="1" colspan="1">2 (5%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1 (3%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Assay make</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;in-house</td><td align="center" rowspan="1" colspan="1">21 (50%)</td><td align="center" rowspan="1" colspan="1">10 (43%)</td><td align="center" rowspan="1" colspan="1">11 (29%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;commercial</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">20 (48%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">10 (43%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">15 (39%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;not specified</td><td align="center" rowspan="1" colspan="1">1 (2%)</td><td align="center" rowspan="1" colspan="1">3 (13%)</td><td align="center" rowspan="1" colspan="1">12 (32%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">Target protein<xref ref-type="table-fn" rid="t004fn003">**</xref></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;whole virus</td><td align="center" rowspan="1" colspan="1">32 (76%)</td><td align="center" rowspan="1" colspan="1">12 (52%)</td><td align="center" rowspan="1" colspan="1">6 (16%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;envelope</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">7 (17%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">4 (17%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">9 (24%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;not specified</td><td align="center" rowspan="1" colspan="1">3 (7%)</td><td align="center" rowspan="1" colspan="1">7 (30%)</td><td align="center" rowspan="1" colspan="1">21 (55%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1"><bold>Risk of bias summary</bold></td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Assay</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;low risk of bias</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">2 (5%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">8 (35%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">14 (37%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;high risk of bias</td><td align="center" rowspan="1" colspan="1">40 (95%)</td><td align="center" rowspan="1" colspan="1">15 (65%)</td><td align="center" rowspan="1" colspan="1">24 (63%)</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;unclear risk of bias</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">0</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">1 (3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sampling methodology</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;low risk of bias</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">15 (36%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">n/a</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">n/a</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;high risk of bias</td><td align="center" rowspan="1" colspan="1">17 (40%)</td><td align="center" rowspan="1" colspan="1">n/a</td><td align="center" rowspan="1" colspan="1">n/a</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;unclear risk of bias</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">10 (24%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">n/a</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">n/a</td></tr><tr><td align="left" rowspan="1" colspan="1">Response rate</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;low risk of bias</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">6 (14%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">11 (48%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">22 (58%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;high risk of bias</td><td align="center" rowspan="1" colspan="1">1 (3%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;unclear risk of bias</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">35 (83%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">12 (52%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">16 (42%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Precision</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#F2F2F2" rowspan="1" colspan="1">&#x000a0;&#x000a0;High</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">28 (67%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">15 (65%)</td><td align="center" style="background-color:#F2F2F2" rowspan="1" colspan="1">28 (74%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;Low</td><td align="center" rowspan="1" colspan="1">14 (33%)</td><td align="center" rowspan="1" colspan="1">8 (35%)</td><td align="center" rowspan="1" colspan="1">10 (26%)</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>* N = 103 because the study type (i.e. general prevalence, acute febrile illness, or suspected dengue) was not specified in two studies [<xref rid="pntd.0005194.ref051" ref-type="bibr">51</xref>, <xref rid="pntd.0005194.ref057" ref-type="bibr">57</xref>].</p></fn><fn id="t004fn002"><p><sup><bold>&#x02020;</bold></sup>Community study settings also include animal quarantine station (n = 1), blood donation center (n = 5), military (n = 3), and university (n = 1).</p></fn><fn id="t004fn003"><p>** Indicates the target protein for the initial screening assay for studies in which multiple diagnostic assays were utilized.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pntd.0005194.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.t005</object-id><label>Table 5</label><caption><title>Summary of human incidence studies for dengue virus in the Middle East and North Africa (n = 3).</title></caption><alternatives><graphic id="pntd.0005194.t005g" xlink:href="pntd.0005194.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" rowspan="1" colspan="1">Country, Ref.</th><th align="center" rowspan="1" colspan="1">Year(s) of study</th><th align="center" rowspan="1" colspan="1">Duration of follow-up</th><th align="center" rowspan="1" colspan="1">City or governorate</th><th align="center" rowspan="1" colspan="1">Setting; population(age range, years)</th><th align="center" rowspan="1" colspan="1">Study design</th><th align="center" rowspan="1" colspan="1">Sampling</th><th align="center" rowspan="1" colspan="1">Assay type</th><th align="center" rowspan="1" colspan="1">Assay make<sup>+</sup></th><th align="center" rowspan="1" colspan="1">Assay Target</th><th align="center" rowspan="1" colspan="1">Serotype tested</th><th align="center" rowspan="1" colspan="1">Sample size</th><th align="center" rowspan="1" colspan="1">Incidence</th></tr></thead><tbody><tr><td align="left" colspan="13" style="background-color:#D9D9D9" rowspan="1"><bold>Pakistan</bold> (n = 1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Siddiqui [<xref rid="pntd.0005194.ref041" ref-type="bibr">41</xref>]</td><td align="center" rowspan="1" colspan="1">1999&#x02013;2001</td><td align="center" rowspan="1" colspan="1">1999&#x02013;2001</td><td align="center" rowspan="1" colspan="1">Karachi</td><td align="center" rowspan="1" colspan="1">Urban slum; children &#x0003c;16 years of age with undifferentiated febrile illness</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">Active surveillance</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">Diag. Auto.</td><td align="center" rowspan="1" colspan="1">wv</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">1,248</td><td align="center" rowspan="1" colspan="1"><bold>185/100,000</bold></td></tr><tr><td align="left" colspan="13" style="background-color:#D9D9D9" rowspan="1"><bold>Sudan</bold> (n = 2)</td></tr><tr><td align="left" rowspan="1" colspan="1">Seidahmed [<xref rid="pntd.0005194.ref039" ref-type="bibr">39</xref>]</td><td align="center" rowspan="1" colspan="1">2008&#x02013;09</td><td align="center" rowspan="1" colspan="1">12 months</td><td align="center" rowspan="1" colspan="1">Port Sudan City</td><td align="center" rowspan="1" colspan="1">Urban community; general pop. living in houses where DENV-carrying mosquitoes were present (&#x0003c;1&#x02013;80)</td><td align="center" rowspan="1" colspan="1">Pros. coh</td><td align="center" rowspan="1" colspan="1">RSS</td><td align="center" rowspan="1" colspan="1">ELISA IgM</td><td align="center" rowspan="1" colspan="1">PanBio</td><td align="center" rowspan="1" colspan="1">Env</td><td align="center" rowspan="1" colspan="1">1&#x02013;4</td><td align="center" rowspan="1" colspan="1">791</td><td align="center" rowspan="1" colspan="1"><bold>35/10,000</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Seidahmed [<xref rid="pntd.0005194.ref040" ref-type="bibr">40</xref>]</td><td align="center" rowspan="1" colspan="1">2010</td><td align="center" rowspan="1" colspan="1">17 weeks</td><td align="center" rowspan="1" colspan="1">Port Sudan</td><td align="center" rowspan="1" colspan="1">Urban community; general pop.</td><td align="center" rowspan="1" colspan="1">CS</td><td align="center" rowspan="1" colspan="1">Conv.</td><td align="center" rowspan="1" colspan="1">ELISA IgM, NS1, PCR</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">n/s</td><td align="center" rowspan="1" colspan="1">3,765<xref ref-type="table-fn" rid="t005fn001"><sup>&#x02021;</sup></xref></td><td align="center" rowspan="1" colspan="1"><bold>94/10,000</bold></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p><sup>&#x02021;</sup> Reported cases</p></fn><fn id="t005fn002"><p>Abbreviations: CS, cross-sectional; ELISA, enzyme-linked immunosorbent assay; Env, envelope; PCR, polymerase chain reaction; Pros. coh, prospective cohort; RSS, random stratified sampling</p></fn><fn id="t005fn003"><p>Assay Abbreviation: <italic>Diag</italic>. <italic>Auto</italic>. (Diagnostic Automation, CA, USA); <italic>PanBio</italic> (Brisbane, Australia)</p></fn></table-wrap-foot></table-wrap><table-wrap id="pntd.0005194.t006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.t006</object-id><label>Table 6</label><caption><title>Summary of vector infection rate studies for dengue virus in the Middle East and North Africa (n = 3)</title></caption><alternatives><graphic id="pntd.0005194.t006g" xlink:href="pntd.0005194.t006"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Author, Ref.</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Year(s) of data collection</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">City or governorate</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Setting</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Mosquito species</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Assay type</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Sample size</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Infection rate</th><th align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Comments</th></tr></thead><tbody><tr><td align="left" colspan="10" style="background-color:#D9D9D9" rowspan="1"><bold>Pakistan</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Jahan [<xref rid="pntd.0005194.ref042" ref-type="bibr">42</xref>]</td><td align="center" rowspan="1" colspan="1">2011</td><td align="center" rowspan="1" colspan="1">Lahore</td><td align="center" rowspan="1" colspan="1">Urban areas</td><td align="center" rowspan="1" colspan="1"><italic>Ae</italic>. <italic>aegypti</italic></td><td align="center" rowspan="1" colspan="1">Ag-capture ELISA</td><td align="center" rowspan="1" colspan="1">114 pools (n = 570 mosquitoes)</td><td align="center" rowspan="1" colspan="1"><bold>27.2%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"><italic>Ae</italic>. <italic>albopictus</italic></td><td align="center" rowspan="1" colspan="1">Ag-capture ELISA</td><td align="center" rowspan="1" colspan="1">4 pools (n = 20 mosquitoes)</td><td align="center" rowspan="1" colspan="1"><bold>25%</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="9" style="background-color:#D9D9D9" rowspan="1"><bold>Yemen</bold></td></tr><tr><td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Zayed [<xref rid="pntd.0005194.ref043" ref-type="bibr">43</xref>]</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">2010&#x02013;11</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">Al Hodayda</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">houses of CHIKV cases at Eritrean refugee camp</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"><italic>Ae</italic>. <italic>aegypti</italic></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">RT-PCR</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">11 pools (n = 30 mosquitoes)</td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1"><bold>0%</bold></td><td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">17 <italic>Culex spp</italic>. mosquitoes were also negative for DENV RNA.</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t006fn001"><p>Abbreviations: RT-PCR, reverse transcription-polymerase chain reaction</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec017"><title>Risk of bias assessment results</title><p>The quality assessment for each study is found in <xref ref-type="supplementary-material" rid="pntd.0005194.s003">S1 Table</xref> and a summary of the precision and risk of bias assessment is found in <xref rid="pntd.0005194.t004" ref-type="table">Table 4</xref>. In brief, most studies (&#x02265;65%) contained high precision as defined by a sample size of &#x02265;100 participants. A minority (36%) of general population seroprevalence studies utilized some form of random sampling, and response rates were either &#x0003c;80% or not reported in 86% of general population studies. VNT or a biologic confirmatory assay (i.e. cell culture, PCR, and NS1 ELISA) was performed in 5% and 36% of general population seroprevalence and acute DENV infection studies, respectively, entailing low ROB for the assays used.</p></sec><sec id="sec018"><title>Dengue outbreaks and <italic>Aedes</italic> occurrence</title><p>Reported outbreaks of DENV in the region were gathered through citations collected from the search databases (<xref ref-type="supplementary-material" rid="pntd.0005194.s004">S2 Table</xref>) and mapped along with the geographic distribution of prevalence studies in <xref ref-type="fig" rid="pntd.0005194.g002">Fig 2</xref>. For DENV, 81 outbreaks were reported from 9 countries in the region from 1941&#x02013;2015, including sentinel reports of autochthonous transmission in Egypt (2010) and Yemen (1983). Reports contained variable descriptions of outbreaks including &#x02018;estimated&#x02019;, &#x02018;suspected&#x02019;, &#x02018;reported&#x02019;, and/or laboratory &#x02018;confirmed&#x02019; cases (<xref ref-type="supplementary-material" rid="pntd.0005194.s004">S2 Table</xref>). The definition that qualified each event as an outbreak was unclear in most instances. Outbreaks of DENV serotypes 1&#x02013;3 were reported from countries surrounding the Red Sea and DENV-4 was only reported from Pakistan [<xref rid="pntd.0005194.ref120" ref-type="bibr">120</xref>, <xref rid="pntd.0005194.ref121" ref-type="bibr">121</xref>]. Although, in general, DENV serotypes were not reported consistently.</p><p>Published reports of <italic>Ae</italic>. <italic>aegypti and Ae</italic>. <italic>albopictus</italic> occurrence are recorded in <xref ref-type="supplementary-material" rid="pntd.0005194.s005">S3 Table</xref> and mapped by country in <xref ref-type="fig" rid="pntd.0005194.g003">Fig 3</xref>. <italic>Ae</italic>. <italic>aegypti</italic> occurrence was reported in 11 MENA countries and historically (i.e. prior to 1960) in Algeria, Libya, Morocco, Syria, and Tunisia. <italic>Ae</italic>. <italic>albopictus</italic> was reported in seven MENA countries, including Algeria, Palestine, and Syria, countries where <italic>Ae</italic>. <italic>aegypti</italic> is not currently reported. No published reports of <italic>Ae</italic>. <italic>aegypti</italic> or <italic>Ae</italic>. <italic>albopictus</italic> occurrence (or DENV outbreaks) were identified in seven MENA countries: Bahrain, Iran, Iraq, Jordan, Kuwait, Qatar, and United Arab Emirates. Since 2005, <italic>Ae</italic>. <italic>aegypti</italic> and/or <italic>Ae</italic>. <italic>albopictus</italic> occurrence has been documented in Afghanistan, Algeria, Lebanon, Oman, Palestine, Syria, and Turkey, though autochthonous transmission of DENV has not yet been reported from these countries.</p><fig id="pntd.0005194.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0005194.g003</object-id><label>Fig 3</label><caption><title>Country-level distribution of <italic>Aedes aegypti</italic> and <italic>Aedes albopictus</italic> occurrence in the Middle East and North Africa.</title></caption><graphic xlink:href="pntd.0005194.g003"/></fig></sec></sec><sec sec-type="conclusions" id="sec019"><title>Discussion</title><p>Our study offers an assessment of published prevalence, incidence, and outbreak reports pertaining to the epidemiology of dengue in the MENA region. Based on the study results, the MENA contains two apparent subregions known to harbor DENV: 1) Pakistan, and 2) the Red Sea countries (Djibouti, Egypt, Saudi Arabia, Somalia, Sudan, and Yemen). No seroprevalence or outbreak data was identified across broad areas of the MENA, however, including some <italic>Aedes</italic> endemic areas. There was also a paucity of reports estimating human incidence and vector infection rates. These findings suggest priorities for future research. However, they also challenge efforts to synthesize and compare the inter- and intra-country epidemiology of DENV in the region.</p><sec id="sec020"><title>Dengue seroprevalence in the MENA</title><p>In our review, Pakistan reported the highest number of prevalence studies and the broadest study coverage among MENA countries. Multiple studies reported &#x0003e;20% prevalence in both general population and those with undifferentiated AFI [<xref rid="pntd.0005194.ref001" ref-type="bibr">1</xref>, <xref rid="pntd.0005194.ref106" ref-type="bibr">106</xref>, <xref rid="pntd.0005194.ref122" ref-type="bibr">122</xref>&#x02013;<xref rid="pntd.0005194.ref124" ref-type="bibr">124</xref>]. DENV serotypes 1&#x02013;4 are known to circulate in Pakistan, unlike other MENA countries [<xref rid="pntd.0005194.ref082" ref-type="bibr">82</xref>]. Pakistan also reported the largest number of confirmed cases among all DENV outbreaks in the MENA, with 21,580 cases reported during the 2011 DENV-2 outbreak [<xref rid="pntd.0005194.ref079" ref-type="bibr">79</xref>, <xref rid="pntd.0005194.ref120" ref-type="bibr">120</xref>] (<xref ref-type="supplementary-material" rid="pntd.0005194.s004">S2 Table</xref>).</p><p>In the Red Sea region, multiple general population and AFI population IgG seroprevalence measures exceeding 20% were published from in Djibouti, Saudi Arabia, Somalia, Sudan, and Yemen within the past decade (<xref rid="pntd.0005194.t003" ref-type="table">Table 3</xref>) along with multiple confirmed outbreaks of DENV serotypes 1&#x02013;3 since the 1980s (<xref ref-type="supplementary-material" rid="pntd.0005194.s004">S2 Table</xref>). DENV-4 has not yet been identified in this subregion to our knowledge. Although reported outbreaks and cases often localize along the Red Sea coastline in these countries [<xref rid="pntd.0005194.ref001" ref-type="bibr">1</xref>], seroprevalence studies suggest a broader distribution of DENV infections that are likely underdetected (<xref ref-type="fig" rid="pntd.0005194.g002">Fig 2</xref>). This is illustrated by the sentinel report of a DENV-infected traveler returning from Yemen in 1983 [<xref rid="pntd.0005194.ref125" ref-type="bibr">125</xref>], despite the first outbreaks of DENV in Yemen and Saudi Arabia not being reported until 1994 [<xref rid="pntd.0005194.ref126" ref-type="bibr">126</xref>&#x02013;<xref rid="pntd.0005194.ref128" ref-type="bibr">128</xref>]. Our search also identified no published prevalence studies or outbreaks in Egypt after 1969 until a dengue outbreak was reported in November 2015 [<xref rid="pntd.0005194.ref010" ref-type="bibr">10</xref>]. However, DENV transmission was suggested years prior by a report of two travelers diagnosed with dengue after returning from southern Egypt in 2011 [<xref rid="pntd.0005194.ref129" ref-type="bibr">129</xref>] and the identification of <italic>Ae</italic>. <italic>aegypti</italic> in southern Egypt that same year [<xref rid="pntd.0005194.ref130" ref-type="bibr">130</xref>]. It is plausible that undetected DENV transmission had been occurring in Egypt prior to this outbreak. However, it is not clear whether this and other recent outbreaks represent increasing incidence, increasing detection, or both, amidst the heterogeneity in study coverage and reporting in the MENA.</p></sec><sec id="sec021"><title>Clinical and methodological diversity among studies</title><p>An important finding in our study was the clinical and methodological diversity among DENV prevalence studies. This diversity represents a challenge to synthesizing the epidemiologic literature for DENV in the MENA. Clinically, studies represented a diversity of human populations of different ages and demographics, in different years, and different locations and transmission contexts. Ninety-six percent of studies from Afghanistan, Pakistan, Saudi Arabia, Somalia, and Yemen were conducted during or prior to 1990. However, 53% of studies in other MENA countries were conducted prior to 1990, when study methods and DENV epidemiology may have been different. Methodologically, most studies utilized convenience samples without reporting response rates, entailing high risk of bias and uncertainty in the representativeness of reported measures (<xref rid="pntd.0005194.t004" ref-type="table">Table 4</xref>). These findings, along with the high variability in regional study coverage, precluded meta-analyses of the available data.</p></sec><sec id="sec022"><title>Flavivirus cross-reactivity</title><p>Serologic cross-reactions remain a challenge to seroepidemiologic studies for DENV and other flaviviruses. Viral neutralization tests, considered the gold standard serologic assay for DENV, were performed in only 5% of general population seroprevalence studies in our review. Compared to ELISAs, seroprevalence measures were 22&#x02013;86% lower by secondary/confirmatory testing with immunofluorescence or VNT in our review [<xref rid="pntd.0005194.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0005194.ref036" ref-type="bibr">36</xref>, <xref rid="pntd.0005194.ref037" ref-type="bibr">37</xref>, <xref rid="pntd.0005194.ref113" ref-type="bibr">113</xref>]. This illustrates the potential uncertainty surrounding the reliability of ELISAs in DENV serologic studies, particularly in areas where the prevalence of antigenically similar viruses is broad or unknown. West Nile virus (WNV), for example, is thought to be distributed across the MENA on account of its ubiquitous <italic>Culex spp</italic>. vector and migratory bird flyways [<xref rid="pntd.0005194.ref131" ref-type="bibr">131</xref>&#x02013;<xref rid="pntd.0005194.ref133" ref-type="bibr">133</xref>]. With up to 80% of WNV infections occurring subclinically, the potential for serologic cross-reactions with DENV antibody assays must be considered. Yellow fever vaccine-derived and natural antibodies may also cross-react with anti-DENV antibodies, especially relevant in YFV endemic regions such as Sudan [<xref rid="pntd.0005194.ref038" ref-type="bibr">38</xref>, <xref rid="pntd.0005194.ref107" ref-type="bibr">107</xref>, <xref rid="pntd.0005194.ref111" ref-type="bibr">111</xref>]. As the emergence of zika virus in the Western Hemisphere or the re-emergence of YFV has shown, serologic assays with low specificity are inadequate to tackle the epidemiologic challenges of emerging arboviral diseases [<xref rid="pntd.0005194.ref134" ref-type="bibr">134</xref>].</p></sec><sec id="sec023"><title>Heterogeneity in dengue outbreak reports</title><p>Our review identified DENV outbreaks in over a third of MENA countries, with most outbreaks reported from Pakistan, Sudan, and Saudi Arabia (<xref ref-type="supplementary-material" rid="pntd.0005194.s004">S2 Table</xref>). Outbreaks varied widely across time and space in the MENA: reported cases varied from &#x0003c;10 to &#x0003e;100,000 over a span of months to years, reported from the village level to the level of the province and region. This presents a challenge to epidemiologic monitoring and policy planning for DENV, as use of different outbreak definitions results in differences in early detection and response [<xref rid="pntd.0005194.ref030" ref-type="bibr">30</xref>]. There is currently no consensus on how to define DENV outbreaks, and adopting a common definition for the MENA is challenging given the region&#x02019;s heterogeneous infection pressures, multiple DENV serotypes, and variable surveillance and detection capacity. At present, assessing whether a reported transmission event in the MENA significantly deviates from baseline transmission, and thus constitutes an outbreak, is often unclear.</p></sec><sec id="sec024"><title>Risk factors and research priorities</title><p>Our study did not identify confirmed DENV transmission in any of the MENA countries west of Egypt and east of Saudi Arabia until Pakistan (<xref ref-type="fig" rid="pntd.0005194.g002">Fig 2</xref>). However, the paucity of published data in these sub-regions does not preclude the possibility of unrecognized transmission in some areas or the risk of emergence in others. Indeed, modeling studies suggest ecologic niches for <italic>Aedes</italic> along the coastal Mediterranean Basin of North Africa [<xref rid="pntd.0005194.ref001" ref-type="bibr">1</xref>, <xref rid="pntd.0005194.ref123" ref-type="bibr">123</xref>, <xref rid="pntd.0005194.ref135" ref-type="bibr">135</xref>], and <italic>Ae</italic>. <italic>albopictus</italic> and/or <italic>Ae</italic>. <italic>aegypti</italic> has been recently reported in Algeria, Lebanon, Palestine, Syria, and Turkey [<xref rid="pntd.0005194.ref005" ref-type="bibr">5</xref>, <xref rid="pntd.0005194.ref136" ref-type="bibr">136</xref>&#x02013;<xref rid="pntd.0005194.ref140" ref-type="bibr">140</xref>] (<xref ref-type="fig" rid="pntd.0005194.g003">Fig 3</xref> and <xref ref-type="supplementary-material" rid="pntd.0005194.s005">S3 Table</xref>). In contrast, <italic>Ae</italic>. <italic>albopictus</italic> has been identified along the Mediterranean coast of Europe for decades along with local transmission of DENV and chikungunya since 2007 [<xref rid="pntd.0005194.ref141" ref-type="bibr">141</xref>]. Near the Pakistan border, serologic evidence suggests possible DENV transmission in Iran [<xref rid="pntd.0005194.ref014" ref-type="bibr">14</xref>, <xref rid="pntd.0005194.ref051" ref-type="bibr">51</xref>, <xref rid="pntd.0005194.ref053" ref-type="bibr">53</xref>] and Afghanistan [<xref rid="pntd.0005194.ref044" ref-type="bibr">44</xref>], though local transmission has not been confirmed to our knowledge [<xref rid="pntd.0005194.ref053" ref-type="bibr">53</xref>]. The presence of <italic>Aedes</italic> or DENV transmission in these areas should not be ruled out [<xref rid="pntd.0005194.ref053" ref-type="bibr">53</xref>].</p><p>Several ecologic and social factors in the MENA may promote the spread of <italic>Aedes-</italic>borne viruses like DENV. Urbanization [<xref rid="pntd.0005194.ref142" ref-type="bibr">142</xref>] may increase the risk of outbreaks and use of open water storage containers that promote <italic>Ae</italic>. <italic>aegypti</italic> breeding [<xref rid="pntd.0005194.ref001" ref-type="bibr">1</xref>, <xref rid="pntd.0005194.ref039" ref-type="bibr">39</xref>, <xref rid="pntd.0005194.ref043" ref-type="bibr">43</xref>, <xref rid="pntd.0005194.ref055" ref-type="bibr">55</xref>, <xref rid="pntd.0005194.ref095" ref-type="bibr">95</xref>, <xref rid="pntd.0005194.ref111" ref-type="bibr">111</xref>, <xref rid="pntd.0005194.ref123" ref-type="bibr">123</xref>, <xref rid="pntd.0005194.ref135" ref-type="bibr">135</xref>]. Heavy rainfall has been implicated in DENV outbreaks in Sudan, Djibouti, and Yemen [<xref rid="pntd.0005194.ref012" ref-type="bibr">12</xref>, <xref rid="pntd.0005194.ref047" ref-type="bibr">47</xref>, <xref rid="pntd.0005194.ref143" ref-type="bibr">143</xref>, <xref rid="pntd.0005194.ref144" ref-type="bibr">144</xref>], which may become increasingly unpredictable through climate change [<xref rid="pntd.0005194.ref145" ref-type="bibr">145</xref>]. Armed conflicts and economic turmoil in Iraq, Syria, and Yemen may render these areas vulnerable to vector-borne diseases while diminishing surveillance and response [<xref rid="pntd.0005194.ref146" ref-type="bibr">146</xref>]. Inter-regional migration poses risk for imported DENV, as millions of migrants travel from DENV-endemic countries to the Arabian Peninsula [<xref rid="pntd.0005194.ref111" ref-type="bibr">111</xref>, <xref rid="pntd.0005194.ref126" ref-type="bibr">126</xref>, <xref rid="pntd.0005194.ref146" ref-type="bibr">146</xref>&#x02013;<xref rid="pntd.0005194.ref149" ref-type="bibr">149</xref>] and to Mecca, Saudi Arabia to attend Umra and Hajj [<xref rid="pntd.0005194.ref126" ref-type="bibr">126</xref>]. Intra-regionally, heavy commerce in the Red Sea region likely drives DENV serotype mixing and spread [<xref rid="pntd.0005194.ref116" ref-type="bibr">116</xref>, <xref rid="pntd.0005194.ref148" ref-type="bibr">148</xref>], as evidenced by multiple DENV outbreaks occurring at port cities in Djibouti [<xref rid="pntd.0005194.ref037" ref-type="bibr">37</xref>, <xref rid="pntd.0005194.ref045" ref-type="bibr">45</xref>], Saudi Arabia [<xref rid="pntd.0005194.ref126" ref-type="bibr">126</xref>], Sudan [<xref rid="pntd.0005194.ref039" ref-type="bibr">39</xref>], and Yemen [<xref rid="pntd.0005194.ref116" ref-type="bibr">116</xref>, <xref rid="pntd.0005194.ref148" ref-type="bibr">148</xref>]. Contiguous spread of DENV from Yemen to Oman [<xref rid="pntd.0005194.ref150" ref-type="bibr">150</xref>], or from Pakistan to Iran or Afghanistan [<xref rid="pntd.0005194.ref014" ref-type="bibr">14</xref>], may also pose risk.</p><p>A number of research priorities emerge concerning the epidemiology of DENV in the MENA. First, broader seroepidemiologic coverage in the region is needed. Such studies are efficient means of characterizing infection pressures in populations lacking surveillance and diagnostic capacity. Multiplexed diagnostics are increasingly available and are well-suited for concurrently exploring the distribution other undercharacterized arboviruses in the region (e.g. Alkhumra, Chikungunya, Crimean-Congo Hemorrhagic Fever, O&#x02019;Nyong-nyong, Rift Valley Fever, Sandfly Fever virus complex, Usutu, and West Nile viruses). Second, serologic studies should include methods to minimize cross-reactions, particularly for flaviviruses [<xref rid="pntd.0005194.ref151" ref-type="bibr">151</xref>]. Third, seroepidemiologic studies should incorporate uniformity in study design and enrollment criteria to minimize confounding, such as standard case definitions for studies of &#x02018;suspected&#x02019; dengue [<xref rid="pntd.0005194.ref126" ref-type="bibr">126</xref>]. Ideally this could include population-based sampling that provides baseline data to benchmark the regional impact of these pathogens over the coming years. Fourth, studies should incorporate vector surveillance and infection rates. Such studies are important for understanding transmission dynamics that inform vector control strategies and predict future transmission and disease risk [<xref rid="pntd.0005194.ref123" ref-type="bibr">123</xref>, <xref rid="pntd.0005194.ref135" ref-type="bibr">135</xref>, <xref rid="pntd.0005194.ref141" ref-type="bibr">141</xref>]. Guidelines and tools for calculating vector infection rates are available [<xref rid="pntd.0005194.ref141" ref-type="bibr">141</xref>, <xref rid="pntd.0005194.ref152" ref-type="bibr">152</xref>]. Finally, attaining a meaningful definition of DENV outbreaks in the MENA countries will require a thorough assessment of baseline surveillance, control, and treatment capacities in endemic regions [<xref rid="pntd.0005194.ref030" ref-type="bibr">30</xref>].</p></sec><sec id="sec025"><title>Study limitations</title><p>Our study was limited by its reliance on select databases of peer-reviewed literature screened by one investigator with the exclusion of grey literature which may have provided additional data. Reviewing other <italic>Aedes</italic>-transmitted pathogens or studies reporting <italic>Aedes</italic> distribution in the MENA may also have provided further insights regarding the potential geographic distribution of DENV. Due to the limitations in the content and distribution of studies, we did not perform a meta-analysis nor did we explore bias in overall outcome measures through a funnel plot or Egger test. Non-publication of studies with small or zero effect size or studies targeted to known dengue-endemic areas may have biased the distribution and quantity of DENV studies. The prevalence measures themselves may have been biased through serologic-cross reactions, targeting of older study populations (with higher seroprevalence), and lack of convalescent titers for acute DENV infection studies (possibly underestimating seroprevalence).</p></sec></sec><sec sec-type="conclusions" id="sec026"><title>Conclusions</title><p>DENV seroprevalence in the MENA is high among some populations in the Red Sea region and Pakistan, while recent outbreaks in these subregions suggest increasing DENV incidence driven by ecologic and social factors. Published prevalence and incidence, vector occurrence, and vector infection rates are lacking in broad areas of the MENA and available studies contain methodological limitations. These findings illustrate the need to strengthen programs for surveillance, reporting, and control of DENV and <italic>Aedes</italic> in the MENA, both to define DENV and <italic>Aedes</italic> epidemiology and to mitigate the risk of emerging <italic>Aedes</italic>-transmitted pathogens in the future.</p></sec><sec sec-type="supplementary-material" id="sec027"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pntd.0005194.s001"><label>S1 Fig</label><caption><title>Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) checklist.</title><p>(PDF)</p></caption><media xlink:href="pntd.0005194.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0005194.s002"><label>S2 Fig</label><caption><title>Data sources and search criteria used for the systematic review of dengue virus prevalence and incidence in the Middle East and North Africa.</title><p>(PDF)</p></caption><media xlink:href="pntd.0005194.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0005194.s003"><label>S1 Table</label><caption><title>Precision and risk of bias assessment for dengue prevalence measures in the Middle East and North Africa.</title><p>(PDF)</p></caption><media xlink:href="pntd.0005194.s003.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0005194.s004"><label>S2 Table</label><caption><title>Summary of reported outbreaks and sentinel cases for dengue virus in the Middle East and North Africa.</title><p>(PDF)</p></caption><media xlink:href="pntd.0005194.s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0005194.s005"><label>S3 Table</label><caption><title>Reported <italic>Aedes aegypti</italic> and <italic>Aedes albopictus</italic> occurrence in the Middle East and North Africa.</title><p>(PDF)</p></caption><media xlink:href="pntd.0005194.s005.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We would like to thank Mary Charlson and Carol Mancuso (Weill Cornell Graduate School of Medical Sciences, New York, USA) for their contributions to the study planning and organization, and Ghina Mumtaz, Hiam Chamaitelly, and Karima Chaabna (Weill Cornell Medical College in Qatar) for their assistance with the study methodology.</p></ack><ref-list><title>References</title><ref id="pntd.0005194.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Bhatt</surname><given-names>S</given-names></name>, <name><surname>Gething</surname><given-names>PW</given-names></name>, <name><surname>Brady</surname><given-names>OJ</given-names></name>, <name><surname>Messina</surname><given-names>JP</given-names></name>, <name><surname>Farlow</surname><given-names>AW</given-names></name>, <name><surname>Moyes</surname><given-names>CL</given-names></name>, <etal>et al</etal>
<article-title>The global distribution and burden of dengue</article-title>. <source>Nature</source>. <year>2013</year>;<volume>496</volume>(<issue>7446</issue>):<fpage>504</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nature12060</pub-id>
<?supplied-pmid 23563266?><pub-id pub-id-type="pmid">23563266</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Murray</surname><given-names>NE</given-names></name>, <name><surname>Quam</surname><given-names>MB</given-names></name>, <name><surname>Wilder-Smith</surname><given-names>A</given-names></name>. <article-title>Epidemiology of dengue: past, present and future prospects</article-title>. <source>Clin Epidemiol</source>. <year>2013</year>;<volume>5</volume>:<fpage>299</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.2147/CLEP.S34440</pub-id>
<?supplied-pmid 23990732?><pub-id pub-id-type="pmid">23990732</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Gubler</surname><given-names>DJ</given-names></name>. <article-title>The global resurgence of arboviral diseases</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>1996</year>;<volume>90</volume>(<issue>5</issue>):<fpage>449</fpage>&#x02013;<lpage>51</lpage>. <?supplied-pmid 8944250?><pub-id pub-id-type="pmid">8944250</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>H.R. R.</surname></name>
<article-title>The role of vectors in emerging and re-emerging diseases in the Eastern Mediterranean Region</article-title>. <source>East Mediterr Health J</source>. <year>1996</year>;<volume>2</volume>(<issue>1</issue>):<fpage>61</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Garabedian</surname><given-names>GA</given-names></name>, <name><surname>Matossian</surname><given-names>RM</given-names></name>, <name><surname>Musalli</surname><given-names>MN</given-names></name>. <article-title>Serologic evidence of arbovirus infection in Lebanon. Le Journal medical libanais</article-title>. <year>1971</year>;<source>The Lebanese medical journal</source>. <volume>24</volume>(<issue>4</issue>):<fpage>339</fpage>&#x02013;<lpage>50</lpage>. <?supplied-pmid 5149804?><pub-id pub-id-type="pmid">5149804</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref006"><label>6</label><mixed-citation publication-type="other">World Health Organization. Growing threat of viral haemorrhagic fevers in the Eastern Mediterranean Region: a call for action Regional Office for the Eastern Mediterranean. Cairo, Egypt. Available from: <ext-link ext-link-type="uri" xlink:href="http://applications.emro.who.int/docs/em_rc54_r4_en.pdf?ua=1">http://applications.emro.who.int/docs/em_rc54_r4_en.pdf?ua=1</ext-link>. Accessed 24 July 2014.</mixed-citation></ref><ref id="pntd.0005194.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Hotez</surname><given-names>PJ</given-names></name>, <name><surname>Savioli</surname><given-names>L</given-names></name>, <name><surname>Fenwick</surname><given-names>A</given-names></name>. <article-title>Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2012</year>;<volume>6</volume>(<issue>2</issue>):<fpage>e1475</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0001475</pub-id>
<?supplied-pmid 22389729?><pub-id pub-id-type="pmid">22389729</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Rai</surname><given-names>MA</given-names></name>. <article-title>Epidemic: Control of dengue fever in Pakistan</article-title>. <source>Nature</source>. <year>2011</year>;<volume>479</volume>(<issue>7371</issue>):<fpage>41</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Arya</surname><given-names>SC</given-names></name>, <name><surname>Agarwal</surname><given-names>N</given-names></name>. <article-title>Apropos: An update on the incidence of dengue gaining strength in Saudi Arabia and current control approaches for its vector mosquito</article-title>. <source>Parasites and Vectors</source>. <year>2014</year>;<volume>7</volume>(<issue>1</issue>).</mixed-citation></ref><ref id="pntd.0005194.ref010"><label>10</label><mixed-citation publication-type="other">World Health Organization. Dengue Fever&#x02014;Egypt 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/don/12-november-2015-dengue/en/">http://www.who.int/csr/don/12-november-2015-dengue/en/</ext-link>. Accessed 12 Dec 2015.</mixed-citation></ref><ref id="pntd.0005194.ref011"><label>11</label><mixed-citation publication-type="other">World Health Organization. Neglected tropical diseases: an emerging public health problem in the Eastern Mediterranean Region. 54th Regional Committe meeting, Eastern Mediterranean Region. Cairo, Egypt. 2006. Available from <ext-link ext-link-type="uri" xlink:href="http://applications.emro.who.int/docs/EM_RC54_10e_en.pdf">http://applications.emro.who.int/docs/EM_RC54_10e_en.pdf</ext-link>. Accessed 12 Dec 2015.</mixed-citation></ref><ref id="pntd.0005194.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Malik</surname><given-names>MR</given-names></name>, <name><surname>Mnzava</surname><given-names>A</given-names></name>, <name><surname>Mohareb</surname><given-names>E</given-names></name>, <name><surname>Zayed</surname><given-names>A</given-names></name>, <name><surname>Al Kohlani</surname><given-names>A</given-names></name>, <name><surname>Thabet</surname><given-names>AA</given-names></name>, <etal>et al</etal>
<article-title>Chikungunya outbreak in Al-Hudaydah, Yemen, 2011: epidemiological characterization and key lessons learned for early detection and control</article-title>. <source>J Epidemiol Glob Health</source>. <year>2014</year>;<volume>4</volume>(<issue>3</issue>):<fpage>203</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.jegh.2014.01.004</pub-id>
<?supplied-pmid 25107656?><pub-id pub-id-type="pmid">25107656</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>EH</given-names></name>, <name><surname>Brewer</surname><given-names>TF</given-names></name>, <name><surname>Madoff</surname><given-names>LC</given-names></name>, <name><surname>Pollack</surname><given-names>MP</given-names></name>, <name><surname>Sonricker</surname><given-names>AL</given-names></name>, <name><surname>Keller</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Global capacity for emerging infectious disease detection</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2010</year>;<volume>107</volume>(<issue>50</issue>):<fpage>21701</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1006219107</pub-id>
<?supplied-pmid 21115835?><pub-id pub-id-type="pmid">21115835</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Aghaie</surname><given-names>A</given-names></name>, <name><surname>Aaskov</surname><given-names>J</given-names></name>, <name><surname>Chinikar</surname><given-names>S</given-names></name>, <name><surname>Niedrig</surname><given-names>M</given-names></name>, <name><surname>Banazadeh</surname><given-names>S</given-names></name>, <name><surname>Mohammadpour</surname><given-names>HK</given-names></name>. <article-title>Frequency of dengue virus infection in blood donors in Sistan and Baluchestan province in Iran</article-title>. <source>Transfusion and Apheresis Science</source>. <year>2014</year>;<volume>50</volume>(<issue>1</issue>):<fpage>59</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.transci.2013.07.034</pub-id>
<?supplied-pmid 24332363?><pub-id pub-id-type="pmid">24332363</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Elduma</surname><given-names>AH</given-names></name>, <name><surname>Osman</surname><given-names>WM</given-names></name>. <article-title>Dengue and hepatitis E virus infection in pregnant women in Eastern Sudan, a challenge for diagnosis in an endemic area</article-title>. <source>Pan Afr Med J</source>. <year>2014</year>;<volume>19</volume>:<fpage>391</fpage>
<pub-id pub-id-type="doi">10.11604/pamj.2014.19.391.5439</pub-id>
<?supplied-pmid 25995787?><pub-id pub-id-type="pmid">25995787</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Burt</surname><given-names>FJ</given-names></name>, <name><surname>Rolph</surname><given-names>MS</given-names></name>, <name><surname>Rulli</surname><given-names>NE</given-names></name>, <name><surname>Mahalingam</surname><given-names>S</given-names></name>, <name><surname>Heise</surname><given-names>MT</given-names></name>. <article-title>Chikungunya: a re-emerging virus</article-title>. <source>Lancet</source>. <year>2012</year>;<volume>379</volume>(<issue>9816</issue>):<fpage>662</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(11)60281-X</pub-id>
<?supplied-pmid 22100854?><pub-id pub-id-type="pmid">22100854</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Ali</surname><given-names>F</given-names></name>, <name><surname>Saleem</surname><given-names>T</given-names></name>, <name><surname>Khalid</surname><given-names>U</given-names></name>, <name><surname>Mehmood</surname><given-names>SF</given-names></name>, <name><surname>Jamil</surname><given-names>B</given-names></name>. <article-title>Crimean-congo hemorrhagic fever in a dengue-endemic region: Lessons for the future</article-title>. <source>Journal of Infection in Developing Countries</source>. <year>2010</year>;<volume>4</volume>(<issue>7</issue>):<fpage>459</fpage>&#x02013;<lpage>63</lpage>. <?supplied-pmid 20818095?><pub-id pub-id-type="pmid">20818095</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Watts</surname><given-names>DM</given-names></name>, <name><surname>El-Tigani</surname><given-names>A</given-names></name>, <name><surname>Botros</surname><given-names>BAM</given-names></name>, <name><surname>Salib</surname><given-names>AW</given-names></name>, <name><surname>Olson</surname><given-names>JG</given-names></name>, <name><surname>McCarthy</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Arthropod-borne viral infections associated with a fever outbreak in the Northern Province of Sudan</article-title>. <source>Journal of Tropical Medicine and Hygiene</source>. <year>1994</year>;<volume>97</volume>(<issue>4</issue>):<fpage>228</fpage>&#x02013;<lpage>30</lpage>. <?supplied-pmid 8064945?><pub-id pub-id-type="pmid">8064945</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Bargaoui</surname><given-names>R</given-names></name>, <name><surname>Lecollinet</surname><given-names>S</given-names></name>, <name><surname>Lancelot</surname><given-names>R</given-names></name>. <article-title>Mapping the Serological Prevalence Rate of West Nile fever in Equids, Tunisia</article-title>. <source>Transbound Emerg Dis</source>. <year>2013</year>.</mixed-citation></ref><ref id="pntd.0005194.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Ben Hassine</surname><given-names>T</given-names></name>, <name><surname>De Massis</surname><given-names>F</given-names></name>, <name><surname>Calistri</surname><given-names>P</given-names></name>, <name><surname>Savini</surname><given-names>G</given-names></name>, <name><surname>BelHaj Mohamed</surname><given-names>B</given-names></name>, <name><surname>Ranen</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>First Detection of Co-circulation of West Nile and Usutu Viruses in Equids in the South-west of Tunisia</article-title>. <source>Transbound Emerg Dis</source>. <year>2014</year>;<volume>61</volume>(<issue>5</issue>):<fpage>385</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/tbed.12259</pub-id>
<?supplied-pmid 25065813?><pub-id pub-id-type="pmid">25065813</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref021"><label>21</label><mixed-citation publication-type="book"><name><surname>Higgins</surname><given-names>JP</given-names></name>, <name><surname>Green</surname><given-names>S</given-names></name>. <chapter-title>Cochrane handbook for systematic reviews of interventions</chapter-title>: <publisher-name>Wiley Online Library</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="pntd.0005194.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Moher</surname><given-names>D</given-names></name>, <name><surname>Liberati</surname><given-names>A</given-names></name>, <name><surname>Tetzlaff</surname><given-names>J</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Group</surname><given-names>P</given-names></name>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>PLoS medicine</source>. <year>2009</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e1000097</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id>
<?supplied-pmid 19621072?><pub-id pub-id-type="pmid">19621072</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>McFarland</surname><given-names>W</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>, <name><surname>Mahfoud</surname><given-names>Z</given-names></name>, <name><surname>DeJong</surname><given-names>J</given-names></name>, <name><surname>Riedner</surname><given-names>G</given-names></name>, <name><surname>Forsyth</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>HIV/AIDS in the Middle East and North Africa: new study methods, results, and implications for prevention and care</article-title>. <source>AIDS</source>. <year>2010</year>;<volume>24</volume>
<issue>Suppl 2</issue>:<fpage>S1</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref024"><label>24</label><mixed-citation publication-type="other">Google Translate Mountain View, California, USA. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.translate.google.com/">http://www.translate.google.com/</ext-link>. Accessed 30 Sept 2015.</mixed-citation></ref><ref id="pntd.0005194.ref025"><label>25</label><mixed-citation publication-type="book"><collab>The Cochrane collaboration</collab>. <chapter-title>Cochrane handbook for systematic reviews of interventions</chapter-title>
<publisher-loc>Hoboken (New Jersey)</publisher-loc>: <publisher-name>Wiley-Blackweill</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="pntd.0005194.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Chemaitelly</surname><given-names>H</given-names></name>, <name><surname>Chaabna</surname><given-names>K</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis</article-title>. <source>PloS one</source>. <year>2015</year>;<volume>10</volume>(<issue>8</issue>):<fpage>e0135281</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0135281</pub-id>
<?supplied-pmid 26296200?><pub-id pub-id-type="pmid">26296200</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Mumtaz</surname><given-names>GR</given-names></name>, <name><surname>Weiss</surname><given-names>HA</given-names></name>, <name><surname>Thomas</surname><given-names>SL</given-names></name>, <name><surname>Riome</surname><given-names>S</given-names></name>, <name><surname>Setayesh</surname><given-names>H</given-names></name>, <name><surname>Riedner</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis</article-title>. <source>PLoS medicine</source>. <year>2014</year>;<volume>11</volume>(<issue>6</issue>):<fpage>e1001663</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1001663</pub-id>
<?supplied-pmid 24937136?><pub-id pub-id-type="pmid">24937136</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Chaabna</surname><given-names>K</given-names></name>, <name><surname>Mohamoud</surname><given-names>YA</given-names></name>, <name><surname>Chemaitelly</surname><given-names>H</given-names></name>, <name><surname>Mumtaz</surname><given-names>GR</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa</article-title>. <source>Syst Rev</source>. <year>2014</year>;<volume>3</volume>:<fpage>146</fpage> PubMed Central PMCID: PMCPMC4274704. <pub-id pub-id-type="doi">10.1186/2046-4053-3-146</pub-id>
<?supplied-pmid 25516265?><pub-id pub-id-type="pmid">25516265</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Galea</surname><given-names>S</given-names></name>, <name><surname>Tracy</surname><given-names>M</given-names></name>. <article-title>Participation rates in epidemiologic studies.</article-title>
<source>Ann Epidemiol</source>. <year>2007</year>;<volume>17</volume>(<issue>9</issue>):<fpage>643</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.annepidem.2007.03.013</pub-id>
<?supplied-pmid 17553702?><pub-id pub-id-type="pmid">17553702</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Brady</surname><given-names>OJ</given-names></name>, <name><surname>Smith</surname><given-names>DL</given-names></name>, <name><surname>Scott</surname><given-names>TW</given-names></name>, <name><surname>Hay</surname><given-names>SI</given-names></name>. <article-title>Dengue disease outbreak definitions are implicitly variable</article-title>. <source>Epidemics</source>. <year>2015</year>;<volume>11</volume>:<fpage>92</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.epidem.2015.03.002</pub-id>
<?supplied-pmid 25979287?><pub-id pub-id-type="pmid">25979287</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Darwish</surname><given-names>MA</given-names></name>, <name><surname>Hoogstraal</surname><given-names>H</given-names></name>, <name><surname>Roberts</surname><given-names>TJ</given-names></name>, <name><surname>Ahmed</surname><given-names>IP</given-names></name>, <name><surname>Omar</surname><given-names>F</given-names></name>. <article-title>A sero-epidemiological survey for certain arboviruses (Togaviridae) in Pakistan</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>. <year>1983</year>;<volume>77</volume>(<issue>4</issue>):<fpage>442</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 6314612?><pub-id pub-id-type="pmid">6314612</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Chastel</surname><given-names>C</given-names></name>, <name><surname>Rogues</surname><given-names>G</given-names></name>, <name><surname>Beaucournu-Saguez</surname><given-names>F</given-names></name>. <article-title>A mixed sero-epidemiologic survey on arbovirus-arenavirus in small mammalians in Tunisia</article-title>. <source>Bulletin de la Societe de Pathologie Exotique et de ses Filiales</source>. <year>1977</year>;<volume>70</volume>(<issue>5</issue>):<fpage>471</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 615674?><pub-id pub-id-type="pmid">615674</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Chastel</surname><given-names>C</given-names></name>, <name><surname>Bach Hamba</surname><given-names>D</given-names></name>, <name><surname>Launay</surname><given-names>H</given-names></name>. <article-title>New serosurvey on arbovirus infections in small wild mammals of Tunisia</article-title>. <source>Bulletin de la Societe de Pathologie Exotique et de ses Filiales</source>. <year>1983</year>;<volume>76</volume>(<issue>1</issue>):<fpage>21</fpage>&#x02013;<lpage>33</lpage>. <?supplied-pmid 6839405?><pub-id pub-id-type="pmid">6839405</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Ari</surname><given-names>A</given-names></name>. <article-title>The prevalence and ecology of arboviruses in Turkey</article-title>. <source>Turk hijiyen ve tecrubi biyoloji dergisi</source>. <year>1972</year>;<volume>32</volume>(<issue>2</issue>):<fpage>134</fpage>&#x02013;<lpage>43</lpage>. <?supplied-pmid 4668350?><pub-id pub-id-type="pmid">4668350</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Darwish</surname><given-names>MA</given-names></name>, <name><surname>Ibrahim</surname><given-names>AH</given-names></name>. <article-title>A serological survey on group A and B arbovirus antibodies in Libya</article-title>. <source>Journal of the Egyptian Public Health Association</source>. <year>1974</year>;<volume>49</volume>(<issue>1</issue>):<fpage>20</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 4850294?><pub-id pub-id-type="pmid">4850294</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Omer</surname><given-names>AHS</given-names></name>, <name><surname>McLaren</surname><given-names>ML</given-names></name>, <name><surname>Johnson</surname><given-names>BK</given-names></name>. <article-title>A seroepidemiological survey in the Gezira, Sudan, with special reference to arboviruses</article-title>. <source>Journal of Tropical Medicine and Hygiene</source>. <year>1981</year>;<volume>84</volume>(<issue>2</issue>):<fpage>63</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 7218404?><pub-id pub-id-type="pmid">7218404</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Rodier</surname><given-names>GR</given-names></name>, <name><surname>Gubler</surname><given-names>DJ</given-names></name>, <name><surname>Cope</surname><given-names>SE</given-names></name>, <name><surname>Cropp</surname><given-names>CB</given-names></name>, <name><surname>Soliman</surname><given-names>AK</given-names></name>, <name><surname>Polycarpe</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Epidemic dengue 2 in the city of Djibouti 1991&#x02013;1992</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>. <year>1996</year>;<volume>90</volume>(<issue>3</issue>):<fpage>237</fpage>&#x02013;<lpage>40</lpage>. <?supplied-pmid 8758061?><pub-id pub-id-type="pmid">8758061</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Farnon</surname><given-names>EC</given-names></name>, <name><surname>Gould</surname><given-names>LH</given-names></name>, <name><surname>Griffith</surname><given-names>KS</given-names></name>, <name><surname>Osman</surname><given-names>MS</given-names></name>, <name><surname>El Kholy</surname><given-names>A</given-names></name>, <name><surname>Brair</surname><given-names>ME</given-names></name>, <etal>et al</etal>
<article-title>Household-Based Sero-Epidemiologic Survey after a Yellow Fever Epidemic, Sudan, 2005</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. <year>2010</year>;<volume>82</volume>(<issue>6</issue>):<fpage>1146</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0105</pub-id>
<?supplied-pmid 20519615?><pub-id pub-id-type="pmid">20519615</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Seidahmed</surname><given-names>OME</given-names></name>, <name><surname>Hassan</surname><given-names>SA</given-names></name>, <name><surname>Soghaier</surname><given-names>MA</given-names></name>, <name><surname>Siam</surname><given-names>HAM</given-names></name>, <name><surname>Ahmed</surname><given-names>FTA</given-names></name>, <name><surname>Elkarsany</surname><given-names>MM</given-names></name>, <etal>et al</etal>
<article-title>Spatial and Temporal Patterns of Dengue Transmission along a Red Sea Coastline: A Longitudinal Entomological and Serological Survey in Port Sudan City.</article-title>
<source>PLoS Neglected Tropical Diseases</source>. <year>2012</year>;<volume>6</volume>(<issue>9</issue>).</mixed-citation></ref><ref id="pntd.0005194.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Seidahmed</surname><given-names>OM</given-names></name>, <name><surname>Siam</surname><given-names>HA</given-names></name>, <name><surname>Soghaier</surname><given-names>MA</given-names></name>, <name><surname>Abubakr</surname><given-names>M</given-names></name>, <name><surname>Osman</surname><given-names>HA</given-names></name>, <name><surname>Abd Elrhman</surname><given-names>LS</given-names></name>, <etal>et al</etal>
<article-title>Dengue vector control and surveillance during a major outbreak in a coastal Red Sea area in Sudan</article-title>. <source>East Mediterr Health J</source>. <year>2012</year>;<volume>18</volume>(<issue>12</issue>):<fpage>1217</fpage>&#x02013;<lpage>24</lpage>. <?supplied-pmid 23301396?><pub-id pub-id-type="pmid">23301396</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Siddiqui</surname><given-names>FJ</given-names></name>, <name><surname>Haider</surname><given-names>SR</given-names></name>, <name><surname>Bhutta</surname><given-names>ZA</given-names></name>. <article-title>Endemic Dengue Fever: A seldom recognized hazard for Pakistani children</article-title>. <source>Journal of Infection in Developing Countries</source>. <year>2009</year>;<volume>3</volume>(<issue>4</issue>):<fpage>306</fpage>&#x02013;<lpage>12</lpage>. <?supplied-pmid 19759495?><pub-id pub-id-type="pmid">19759495</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Jahan</surname><given-names>N</given-names></name>. <article-title>Detection of dengue viruses in aedes mosquitoes from different localities of Lahore, Pakistan</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. <year>2013</year>;<issue>1</issue>):<fpage>35</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Zayed</surname><given-names>A</given-names></name>, <name><surname>Awash</surname><given-names>AA</given-names></name>, <name><surname>Esmail</surname><given-names>MA</given-names></name>, <name><surname>Al-Mohamadi</surname><given-names>HA</given-names></name>, <name><surname>Al-Salwai</surname><given-names>M</given-names></name>, <name><surname>Al-Jasari</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Detection of Chikungunya virus in Aedes aegypti during 2011 outbreak in Al Hodayda, Yemen</article-title>. <source>Acta Tropica</source>. <year>2012</year>;<volume>123</volume>(<issue>1</issue>):<fpage>62</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2012.03.004</pub-id>
<?supplied-pmid 22469818?><pub-id pub-id-type="pmid">22469818</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Elyan</surname><given-names>DS</given-names></name>, <name><surname>Moustafa</surname><given-names>L</given-names></name>, <name><surname>Noormal</surname><given-names>B</given-names></name>, <name><surname>Jacobs</surname><given-names>JS</given-names></name>, <name><surname>Aziz</surname><given-names>MA</given-names></name>, <name><surname>Hassan</surname><given-names>KS</given-names></name>, <etal>et al</etal>
<article-title>Serological evidence of Flaviviruses infection among acute febrile illness patients in Afghanistan</article-title>. <source>J Infect Dev Ctries</source>. <year>2014</year>;<volume>8</volume>(<issue>9</issue>):<fpage>1176</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.3855/jidc.4183</pub-id>
<?supplied-pmid 25212082?><pub-id pub-id-type="pmid">25212082</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Salah</surname><given-names>S</given-names></name>, <name><surname>Fox</surname><given-names>E</given-names></name>, <name><surname>Abbatte</surname><given-names>EA</given-names></name>, <name><surname>Constantine</surname><given-names>NT</given-names></name>, <name><surname>Asselin</surname><given-names>P</given-names></name>, <name><surname>Soliman</surname><given-names>AK</given-names></name>. <article-title>A negative human serosurvey of haemorrhagic fever viruses in Djibouti</article-title>. <source>Annales de l'Institut Pasteur Virology</source>. <year>1988</year>;<volume>139</volume>(<issue>4</issue>):<fpage>439</fpage>&#x02013;<lpage>42</lpage>. <?supplied-pmid 2905609?><pub-id pub-id-type="pmid">2905609</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Faulde</surname><given-names>MK</given-names></name>, <name><surname>Spiesberger</surname><given-names>M</given-names></name>, <name><surname>Abbas</surname><given-names>B</given-names></name>. <article-title>Sentinel site-enhanced near-real time surveillance documenting West Nile virus circulation in two Culex mosquito species indicating different transmission characteristics, Djibouti City, Djibouti</article-title>. <source>Journal of the Egyptian Society of Parasitology</source>. <year>2012</year>;<volume>42</volume>(<issue>2</issue>):<fpage>461</fpage>&#x02013;<lpage>74</lpage>. <?supplied-pmid 23214223?><pub-id pub-id-type="pmid">23214223</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Andayi</surname><given-names>F</given-names></name>, <name><surname>Charrel</surname><given-names>RN</given-names></name>, <name><surname>Kieffer</surname><given-names>A</given-names></name>, <name><surname>Richet</surname><given-names>H</given-names></name>, <name><surname>Pastorino</surname><given-names>B</given-names></name>, <name><surname>Leparc-Goffart</surname><given-names>I</given-names></name>, <etal>et al</etal>
<article-title>A sero-epidemiological study of arboviral fevers in Djibouti, horn of Africa</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2014</year>;<volume>8</volume>(<issue>12</issue>):<fpage>e3299</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0003299</pub-id>
<?supplied-pmid 25502692?><pub-id pub-id-type="pmid">25502692</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Mohammed</surname><given-names>YS</given-names></name>, <name><surname>Sekeyova</surname><given-names>M</given-names></name>, <name><surname>Gresikova</surname><given-names>M</given-names></name>, <name><surname>el-Dawala</surname><given-names>K</given-names></name>. <article-title>Studies on arboviruses in Egypt. I. Hemagglutination-inhibition antibodies against arboviruses in human population of Alexandria and Abyss areas</article-title>. <source>The Indian journal of medical research</source>. <year>1968</year>;<volume>56</volume>(<issue>4</issue>):<fpage>381</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 5687693?><pub-id pub-id-type="pmid">5687693</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Mohammed</surname><given-names>YS</given-names></name>, <name><surname>Gresikova</surname><given-names>M</given-names></name>, <name><surname>Adamyova</surname><given-names>K</given-names></name>, <name><surname>Ragib</surname><given-names>AHe-DK</given-names></name>. <article-title>Studies on arboviruses in Egypt. II. Contribution of arboviruses to the aetiology of undiagnosed fever among children</article-title>. <source>The Journal of hygiene</source>. <year>1970</year>;<volume>68</volume>(<issue>3</issue>):<fpage>491</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 5272347?><pub-id pub-id-type="pmid">5272347</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Darwish</surname><given-names>MA</given-names></name>, <name><surname>Ibrahim</surname><given-names>AH</given-names></name>. <article-title>Prevalence of antibodies to arboviruses in Egypt. Results of a serologic survey among 1,113 university students</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. <year>1975</year>;<volume>24</volume>(<issue>6</issue> I):<fpage>981</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">173201</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Saidi</surname><given-names>S</given-names></name>. <article-title>Survey of antibodies to arboviruses in human population of Iran</article-title>. <source>Pahlavi Medical Journal</source>. <year>1971</year>;<volume>2</volume>(<issue>3</issue>):<fpage>485</fpage>&#x02013;<lpage>90</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Saidi</surname><given-names>S</given-names></name>. <article-title>Viral antibodies in preschool children from the Caspian area, Iran</article-title>. <source>Iranian Journal of Public Health</source>. <year>1974</year>;<volume>3</volume>(<issue>2</issue>):<fpage>83</fpage>&#x02013;<lpage>91</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Chinikar</surname><given-names>S</given-names></name>, <name><surname>Ghiasi</surname><given-names>SM</given-names></name>, <name><surname>Shah-Hosseini</surname><given-names>N</given-names></name>, <name><surname>Mostafavi</surname><given-names>E</given-names></name>, <name><surname>Moradi</surname><given-names>M</given-names></name>, <name><surname>Khakifirouz</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Preliminary study of dengue virus infection in Iran</article-title>. <source>Travel Medicine and Infectious Disease</source>. <year>2013</year>;<volume>11</volume>(<issue>3</issue>):<fpage>166</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.tmaid.2012.10.001</pub-id>
<?supplied-pmid 23194952?><pub-id pub-id-type="pmid">23194952</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Ibrahim</surname><given-names>SH</given-names></name>, <name><surname>Darwish</surname><given-names>MA</given-names></name>, <name><surname>Wahdan</surname><given-names>MH</given-names></name>, <name><surname>El Ghoroury</surname><given-names>AAA</given-names></name>. <article-title>Survey for antibodies against group B arboviruses in man in Kuwait</article-title>. <source>Journal of the Egyptian Public Health Association</source>. <year>1974</year>;<volume>49</volume>(<issue>2</issue>):<fpage>77</fpage>&#x02013;<lpage>95</lpage>. <?supplied-pmid 4427084?><pub-id pub-id-type="pmid">4427084</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Al-Nakib</surname><given-names>W</given-names></name>, <name><surname>Lloyd</surname><given-names>G</given-names></name>, <name><surname>El-Mekki</surname><given-names>A</given-names></name>, <name><surname>Platt</surname><given-names>G</given-names></name>, <name><surname>Beeson</surname><given-names>A</given-names></name>, <name><surname>Southee</surname><given-names>T</given-names></name>. <article-title>Preliminary report on arbovirus-antibody prevalence among patients in Kuwait: evidence of Congo/Crimean virus infection</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>. <year>1984</year>;<volume>78</volume>(<issue>4</issue>):<fpage>474</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 6435292?><pub-id pub-id-type="pmid">6435292</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Pacsa</surname><given-names>A</given-names></name>, <name><surname>Mustafa</surname><given-names>AS</given-names></name>, <name><surname>Chaturvedi</surname><given-names>UC</given-names></name>. <article-title>Study of dengue virus infection in Kuwait</article-title>. <source>Dengue Bulletin</source>. <year>2002</year>;<volume>26</volume>(pp <fpage>113</fpage>&#x02013;<lpage>117</lpage>).</mixed-citation></ref><ref id="pntd.0005194.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Hatem</surname><given-names>J</given-names></name>. <article-title>The role of the laboratory in the surveillance of viral diseases in Lebanon</article-title>. <source>Journal Medical Libanais</source>. <year>1972</year>;<volume>25</volume>(<issue>3</issue>):<fpage>151</fpage>&#x02013;<lpage>65</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Akram</surname><given-names>DS</given-names></name>, <name><surname>Igarashi</surname><given-names>A</given-names></name>, <name><surname>Takasu</surname><given-names>T</given-names></name>. <article-title>Dengue virus infection among children with undifferentiated fever in Karachi</article-title>. <source>Indian journal of pediatrics</source>. <year>1998</year>;<volume>65</volume>(<issue>5</issue>):<fpage>735</fpage>&#x02013;<lpage>40</lpage>. <?supplied-pmid 10773930?><pub-id pub-id-type="pmid">10773930</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Tariq W</surname><given-names>KS</given-names></name>, <name><surname>Hussain</surname><given-names>A</given-names></name>, <name><surname>Bhani</surname><given-names>E</given-names></name>. <article-title>Outbreak of dengue fever in Mangla and Mirpur area</article-title>. <source>Pak J Pathol</source>. <year>2006</year>;<volume>17</volume>(<issue>3</issue>):<fpage>122</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Jamil</surname><given-names>B</given-names></name>, <name><surname>Hasan</surname><given-names>R</given-names></name>, <name><surname>Zafar</surname><given-names>A</given-names></name>, <name><surname>Bewley</surname><given-names>K</given-names></name>, <name><surname>Chamberlain</surname><given-names>J</given-names></name>, <name><surname>Mioulet</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Dengue virus serotype 3, Karachi, Pakistan</article-title>. <source>Emerg Infect Dis</source>. <year>2007</year>;<volume>13</volume>(<issue>1</issue>):<fpage>182</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">17370547</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>E</given-names></name>, <name><surname>Mehraj</surname><given-names>V</given-names></name>, <name><surname>Nasir</surname><given-names>A</given-names></name>, <name><surname>Khan</surname><given-names>NA</given-names></name>, <name><surname>Billoo</surname><given-names>B</given-names></name>, <name><surname>Moatter</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Evaluation of two ELISA Assay Kits against RT-PCR for diagnosis of Dengue Virus Infection in a Hospital Setting in Karachi, Pakistan</article-title>. <source>Journal of the Pakistan Medical Association</source>. <year>2009</year>;<volume>59</volume>(<issue>6</issue>):<fpage>390</fpage>&#x02013;<lpage>4</lpage>. <?supplied-pmid 19534376?><pub-id pub-id-type="pmid">19534376</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>E</given-names></name>, <name><surname>Hasan</surname><given-names>R</given-names></name>, <name><surname>Mehraj</surname><given-names>V</given-names></name>, <name><surname>Nasir</surname><given-names>A</given-names></name>, <name><surname>Siddiqui</surname><given-names>J</given-names></name>, <name><surname>Hewson</surname><given-names>R</given-names></name>. <article-title>Co-circulations of two genotypes of dengue virus in 2006 out-break of dengue hemorrhagic fever in Karachi, Pakistan</article-title>. <source>Journal of Clinical Virology</source>. <year>2008</year>;<volume>43</volume>(<issue>2</issue>):<fpage>176</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2008.06.003</pub-id>
<?supplied-pmid 18639489?><pub-id pub-id-type="pmid">18639489</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Koo</surname><given-names>C</given-names></name>, <name><surname>Nasir</surname><given-names>A</given-names></name>, <name><surname>Hapuarachchi</surname><given-names>HC</given-names></name>, <name><surname>Lee</surname><given-names>KS</given-names></name>, <name><surname>Hasan</surname><given-names>Z</given-names></name>, <name><surname>Ng</surname><given-names>LC</given-names></name>, <etal>et al</etal>
<article-title>Evolution and heterogeneity of multiple serotypes of Dengue virus in Pakistan, 2006&#x02013;2011</article-title>. <source>Virology Journal</source>. <year>2013</year>.</mixed-citation></ref><ref id="pntd.0005194.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>AH</given-names></name>, <name><surname>Hayat</surname><given-names>AS</given-names></name>, <name><surname>Masood</surname><given-names>N</given-names></name>, <name><surname>Solangi</surname><given-names>NM</given-names></name>, <name><surname>Shaikh</surname><given-names>TZ</given-names></name>. <article-title>Frequency and clinical presentation of dengue fever at tertiary care hospital of Hyderabad/Jamshoro</article-title>. <source>Journal of the Liaquat University of Medical and Health Sciences</source>. <year>2010</year>;<volume>9</volume>(<issue>2</issue>):<fpage>88</fpage>&#x02013;<lpage>94</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>E</given-names></name>, <name><surname>Kisat</surname><given-names>M</given-names></name>, <name><surname>Khan</surname><given-names>N</given-names></name>, <name><surname>Nasir</surname><given-names>A</given-names></name>, <name><surname>Ayub</surname><given-names>S</given-names></name>, <name><surname>Hasan</surname><given-names>R</given-names></name>. <article-title>Demographic and clinical features of dengue fever in Pakistan from 2003&#x02013;2007: A retrospective cross- sectional study</article-title>. <source>PLoS ONE</source>. <year>2010</year>;<volume>5</volume>(<issue>9</issue>):<fpage>1</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Abbasi</surname><given-names>A</given-names></name>, <name><surname>Butt</surname><given-names>N</given-names></name>, <name><surname>Sheikh</surname><given-names>QH</given-names></name>, <name><surname>Bhutto</surname><given-names>AR</given-names></name>, <name><surname>Munir</surname><given-names>SM</given-names></name>, <name><surname>Ahmed</surname><given-names>SM</given-names></name>. <article-title>Clinical features, diagnostic techniques and management of dual dengue and Malaria infection</article-title>. <source>Journal of the College of Physicians and Surgeons Pakistan</source>. <year>2009</year>;<volume>19</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 19149976?><pub-id pub-id-type="pmid">19149976</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Tahir Z</surname><given-names>HS</given-names></name>, <name><surname>Chaudhry</surname><given-names>A</given-names></name>. <article-title>Spatial and seasonal varation of dengue fever in Lahore 2008</article-title>. <source>Biomedica</source>. <year>2010</year>;<volume>26</volume>(<season>Jul-Dec</season><issue>.</issue>):<fpage>166</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Murad</surname><given-names>H</given-names></name>, <name><surname>Asahar</surname><given-names>RJ</given-names></name>, <name><surname>Zaheen</surname><given-names>M</given-names></name>, <name><surname>Shawali</surname><given-names>R</given-names></name>. <article-title>Outbreak investigation of Dengue fever in Sundia, Chakaiser, Shangla, Pakistan-2008</article-title>. <source>Journal of Ayub Medical College, Abbottabad: JAMC</source>. <year>2014</year>;<volume>26</volume>(<issue>4</issue>):<fpage>571</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 25672190?><pub-id pub-id-type="pmid">25672190</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Mahmood K</surname><given-names>AH</given-names></name>, <name><surname>Tahir</surname><given-names>M</given-names></name>. <article-title>Incidence of dengue haemorrhagic fever in local population of Lahore, Pakistan</article-title>. <source>Biomedica</source>. <year>2009</year>;<volume>25</volume>(Jul.-Dec.):<fpage>93</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Kidwai</surname><given-names>AA</given-names></name>, <name><surname>Jamal</surname><given-names>Q</given-names></name>, <name><surname>Saher</surname></name>, <name><surname>Mehrunnisa</surname></name>, <name><surname>Farooqi</surname><given-names>FU</given-names></name>, <name><surname>Saleem</surname><given-names>U</given-names></name>. <article-title>Serodiagnosis of dengue infection using rapid immunochromatography test in patients with probable dengue infection</article-title>. <source>J Pak Med Assoc</source>. <year>2010</year>;<volume>60</volume>(<issue>11</issue>):<fpage>936</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 21375198?><pub-id pub-id-type="pmid">21375198</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Zafar</surname><given-names>H</given-names></name>, <name><surname>Hayyat</surname><given-names>A</given-names></name>, <name><surname>Akhtar</surname><given-names>N</given-names></name>, <name><surname>Rizwan</surname><given-names>SF</given-names></name>. <article-title>Prevalence of undifferentiated fever in adults of Rawalpindi having primary dengue fever</article-title>. <source>JPMA The Journal of the Pakistan Medical Association</source>. <year>2013</year>;<volume>63</volume>(<issue>6</issue>):<fpage>770</fpage>&#x02013;<lpage>1</lpage>. <?supplied-pmid 23901683?><pub-id pub-id-type="pmid">23901683</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Zafar</surname><given-names>H</given-names></name>, <name><surname>Hayyat</surname><given-names>A</given-names></name>, <name><surname>Akhtar</surname><given-names>N</given-names></name>. <article-title>Incidence of primary dengue viral infection in healthy adults of Rawalpindi, Pakistan</article-title>. <source>Journal of the Pakistan Medical Association</source>. <year>2011</year>;<volume>61</volume>(<issue>10</issue>):<fpage>1030</fpage>&#x02013;<lpage>1</lpage>. <?supplied-pmid 22356047?><pub-id pub-id-type="pmid">22356047</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Qureshi KA</surname><given-names>LA</given-names></name>, <name><surname>Samoo</surname><given-names>AH</given-names></name>. <article-title>Screening for dengue virus infection at GMMMC hospital, Sukkur</article-title>. <source>Medical Forum Monthly</source>. <year>2013</year>;<volume>24</volume>(<issue>4</issue>):<fpage>6</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Khan H</surname><given-names>KQ</given-names></name>, <name><surname>Khan</surname><given-names>BA</given-names></name>, <name><surname>Arif</surname><given-names>M</given-names></name>, <name><surname>Raza</surname><given-names>AAH</given-names></name>. <article-title>Retrospective analysis of 68 cases of dengue fever</article-title>. <source>Pak J Med Res</source>. <year>2012</year>;<volume>51</volume>(<issue>1</issue>):<fpage>18</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Hasan</surname><given-names>SR</given-names></name>, <name><surname>Riaz</surname><given-names>M</given-names></name>, <name><surname>Jafri</surname><given-names>FA</given-names></name>. <article-title>Characteristics and outcome of dengue infection; clinical perspective from a secondary care hospital of Karachi</article-title>. <source>Pakistan Journal of Medical Sciences</source>. <year>2013</year>;<volume>29</volume>(<issue>1</issue>):<fpage>115</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.12669/pjms.291.2742</pub-id>
<?supplied-pmid 24353520?><pub-id pub-id-type="pmid">24353520</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Umar</surname><given-names>S</given-names></name>, <name><surname>Ashraf</surname><given-names>O</given-names></name>, <name><surname>Umar</surname><given-names>M</given-names></name>. <article-title>Characteristics of febrile thrombocytopenia during dengue epidemic 2010 in Rawalpindi, Pakistan</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2011</year>;<volume>15</volume>:<fpage>S114</fpage>&#x02013;<lpage>S115</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Jameel T</surname><given-names>MK</given-names></name>, <name><surname>Ghulam Choudhry</surname><given-names>N</given-names></name>, <name><surname>Afzal</surname><given-names>NP</given-names></name>, <name><surname>Paul</surname><given-names>RF</given-names></name>. <article-title>Changing hematologic parameters in dengue viral infections</article-title>. <source>J Ayub med Coll-Abbotabad-Pak</source>. <year>2012</year>;<volume>24</volume>(<issue>1</issue>):<fpage>3</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Naeem M</surname><given-names>SA</given-names></name>, <name><surname>Batool</surname><given-names>S</given-names></name>, <name><surname>Rubab</surname><given-names>S</given-names></name>, <name><surname>Saba</surname><given-names>T</given-names></name>, <name><surname>Riaz</surname><given-names>T</given-names></name>, <name><surname>Mahmood</surname><given-names>A</given-names></name>. <article-title>Dengue fever; a clinical experience</article-title>
<source>Professional Med J</source>. <year>2014</year>;<volume>23</volume>(<issue>2</issue>):<fpage>243</fpage>&#x02013;<lpage>46</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref079"><label>79</label><mixed-citation publication-type="journal"><name><surname>Ahmed</surname><given-names>S</given-names></name>, <name><surname>Mohammad</surname><given-names>WW</given-names></name>, <name><surname>Hamid</surname><given-names>F</given-names></name>, <name><surname>Akhter</surname><given-names>A</given-names></name>, <name><surname>Afzal</surname><given-names>RK</given-names></name>, <name><surname>Mahmood</surname><given-names>A</given-names></name>. <article-title>The 2011 dengue haemorrhagic fever outbreak in lahore&#x02014;an account of clinical parameters and pattern of haemorrhagic complications</article-title>. <source>Journal of the College of Physicians and Surgeons Pakistan</source>. <year>2013</year>;<volume>23</volume>(<issue>7</issue>):<fpage>463</fpage>&#x02013;<lpage>7</lpage>. <?supplied-pmid 23823947?><pub-id pub-id-type="pmid">23823947</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref080"><label>80</label><mixed-citation publication-type="journal"><name><surname>Ijaz</surname><given-names>T</given-names></name>, <name><surname>Ijaz</surname><given-names>S</given-names></name>, <name><surname>Aslam</surname><given-names>S</given-names></name>, <name><surname>Ahmad</surname><given-names>BM</given-names></name>, <name><surname>Raja</surname><given-names>SA</given-names></name>. <article-title>A laboratory based study of dengue epidemic in the city of Lahore during year 2011</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2014</year>;<volume>21</volume>:<fpage>136</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref081"><label>81</label><mixed-citation publication-type="journal"><name><surname>Rashid A</surname><given-names>KH</given-names></name>, <name><surname>Nadeem</surname><given-names>UR</given-names></name>. <article-title>Dengue Hemorrhagic Fever / dengue shock syndrome</article-title>. <source>Professional Med J</source>. <year>2012</year>;<volume>19</volume>(<issue>5</issue>):<fpage>661</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref082"><label>82</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>MA</given-names></name>, <name><surname>Ellis</surname><given-names>EM</given-names></name>, <name><surname>Tissera</surname><given-names>HA</given-names></name>, <name><surname>Alvi</surname><given-names>MY</given-names></name>, <name><surname>Rahman</surname><given-names>FF</given-names></name>, <name><surname>Masud</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Emergence and Diversification of Dengue 2 Cosmopolitan Genotype in Pakistan, 2011</article-title>. <source>PLoS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>3</issue>).</mixed-citation></ref><ref id="pntd.0005194.ref083"><label>83</label><mixed-citation publication-type="journal"><name><surname>Hasan</surname><given-names>Z</given-names></name>, <name><surname>Atkinson</surname><given-names>B</given-names></name>, <name><surname>Jamil</surname><given-names>B</given-names></name>, <name><surname>Samreen</surname><given-names>A</given-names></name>, <name><surname>Altaf</surname><given-names>L</given-names></name>, <name><surname>Hewson</surname><given-names>R</given-names></name>. <article-title>Short report: Diagnostic testing for hemorrhagic fevers in Pakistan: 2007&#x02013;2013</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. 1243;<volume>91</volume>(<issue>6</issue>):<fpage>1243</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.14-0383</pub-id>
<?supplied-pmid 25311694?><pub-id pub-id-type="pmid">25311694</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref084"><label>84</label><mixed-citation publication-type="journal"><name><surname>Ali</surname><given-names>A</given-names></name>, <name><surname>Rehman</surname><given-names>HU</given-names></name>, <name><surname>Nisar</surname><given-names>M</given-names></name>, <name><surname>Rafique</surname><given-names>S</given-names></name>, <name><surname>Ali</surname><given-names>S</given-names></name>, <name><surname>Hussain</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Seroepidemiology of dengue fever in Khyber Pakhtunkhawa, Pakistan</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2013</year>;<volume>17</volume>(<issue>7</issue>):<fpage>e518</fpage>&#x02013;<lpage>e23</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2013.01.007</pub-id>
<?supplied-pmid 23523057?><pub-id pub-id-type="pmid">23523057</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref085"><label>85</label><mixed-citation publication-type="journal"><name><surname>Hisam</surname><given-names>A</given-names></name>, <name><surname>Mahmood ur</surname><given-names>R</given-names></name>, <name><surname>Khan</surname><given-names>MB</given-names></name>, <name><surname>Kadir</surname><given-names>E</given-names></name>, <name><surname>Azam</surname><given-names>N</given-names></name>. <article-title>Frequency of co-existence of dengue and malaria in patients presenting with acute febrile illness</article-title>. <source>JPMA The Journal of the Pakistan Medical Association</source>. <year>2014</year>;<volume>64</volume>(<issue>3</issue>):<fpage>247</fpage>&#x02013;<lpage>51</lpage>. <?supplied-pmid 24864593?><pub-id pub-id-type="pmid">24864593</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref086"><label>86</label><mixed-citation publication-type="journal"><name><surname>Assir</surname><given-names>MZK</given-names></name>, <name><surname>Masood</surname><given-names>MA</given-names></name>, <name><surname>Ahmad</surname><given-names>HI</given-names></name>. <article-title>Concurrent dengue and malaria infection in Lahore, Pakistan during the 2012 dengue outbreak</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2014</year>;<volume>18</volume>(<issue>1</issue>):<fpage>41</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">24183717</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref087"><label>87</label><mixed-citation publication-type="journal"><name><surname>Fakeeh</surname><given-names>M</given-names></name>, <name><surname>Zaki</surname><given-names>AM</given-names></name>. <article-title>Virologic and serologic surveillance for dengue fever in Jeddah, Saudi Arabia, 1994&#x02013;1999</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. <year>2001</year>;<volume>65</volume>(<issue>6</issue>):<fpage>764</fpage>&#x02013;<lpage>7</lpage>. <?supplied-pmid 11791972?><pub-id pub-id-type="pmid">11791972</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref088"><label>88</label><mixed-citation publication-type="journal"><name><surname>Fakeeh</surname><given-names>M</given-names></name>, <name><surname>Zaki</surname><given-names>AM</given-names></name><article-title>. Dengue in Jeddah, Saudi Arabia, 1994&#x02013;2002</article-title>. <source>Dengue Bulletin</source>. <year>2003</year>;<volume>27</volume>(pp <fpage>13</fpage>&#x02013;<lpage>18</lpage>).</mixed-citation></ref><ref id="pntd.0005194.ref089"><label>89</label><mixed-citation publication-type="journal"><name><surname>Khan</surname><given-names>NA</given-names></name>, <name><surname>Azhar</surname><given-names>EI</given-names></name>, <name><surname>El-Fiky</surname><given-names>S</given-names></name>, <name><surname>Madani</surname><given-names>HH</given-names></name>, <name><surname>Abuljadial</surname><given-names>MA</given-names></name>, <name><surname>Ashshi</surname><given-names>AM</given-names></name>, <etal>et al</etal>
<article-title>Clinical profile and outcome of hospitalized patients during first outbreak of dengue in Makkah, Saudi Arabia</article-title>. <source>Acta Tropica</source>. <year>2008</year>;<volume>105</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2007.09.005</pub-id>
<?supplied-pmid 17983609?><pub-id pub-id-type="pmid">17983609</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref090"><label>90</label><mixed-citation publication-type="journal"><name><surname>Ayyub</surname><given-names>M</given-names></name>, <name><surname>Khazindar</surname><given-names>AM</given-names></name>, <name><surname>Lubbad</surname><given-names>EH</given-names></name>, <name><surname>Barlas</surname><given-names>S</given-names></name>, <name><surname>Alfi</surname><given-names>AY</given-names></name>, <name><surname>Al-Ukayli</surname><given-names>S</given-names></name>. <article-title>Characteristics of dengue fever in a large public hospital, Jeddah, Saudi Arabia</article-title>. <source>Journal of Ayub Medical College, Abbottabad: JAMC</source>. <year>2006</year>;<volume>18</volume>(<issue>2</issue>):<fpage>9</fpage>&#x02013;<lpage>13</lpage>. <?supplied-pmid 16977805?><pub-id pub-id-type="pmid">16977805</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref091"><label>91</label><mixed-citation publication-type="journal"><name><surname>Shahin</surname><given-names>W</given-names></name>, <name><surname>Nassar</surname><given-names>A</given-names></name>, <name><surname>Kalkattawi</surname><given-names>M</given-names></name>, <name><surname>Bokhari</surname><given-names>H</given-names></name>. <article-title>Dengue fever in a tertiary hospital in Makkah, Saudi Arabia</article-title>. <source>Dengue Bulletin</source>. <year>2009</year>;<volume>33</volume>(<issue>1</issue>):<fpage>34</fpage>&#x02013;<lpage>44</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref092"><label>92</label><mixed-citation publication-type="journal"><name><surname>Said SM</surname><given-names>EK</given-names></name>, <name><surname>Alyan</surname><given-names>Z</given-names></name>. <article-title>Benign acute myositis in association with acute dengue viruses' infections</article-title>. <source>Egypt J Neurol Psychiatry Neurosurg</source>. <year>2008</year>;<volume>45</volume>(<issue>1</issue>):<fpage>193</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref093"><label>93</label><mixed-citation publication-type="journal"><name><surname>Memish</surname><given-names>ZA</given-names></name>, <name><surname>Albarrak</surname><given-names>A</given-names></name>, <name><surname>Almazroa</surname><given-names>MA</given-names></name>, <name><surname>Al-Omar</surname><given-names>I</given-names></name>, <name><surname>Alhakeem</surname><given-names>R</given-names></name>, <name><surname>Assiri</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Seroprevalence of Alkhurma and other hemorrhagic fever viruses, Saudi Arabia</article-title>. <source>Emerging Infectious Diseases</source>. <year>2011</year>;<volume>17</volume>(<issue>12</issue>):<fpage>2316</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3201/eid1712.110658</pub-id>
<?supplied-pmid 22172587?><pub-id pub-id-type="pmid">22172587</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref094"><label>94</label><mixed-citation publication-type="journal"><name><surname>Gamil</surname><given-names>MA</given-names></name>, <name><surname>Eisa</surname><given-names>ZM</given-names></name>, <name><surname>Eifan</surname><given-names>SA</given-names></name>, <name><surname>Al-Sum</surname><given-names>BA</given-names></name>. <article-title>Prevalence of dengue fever in Jizan area, Saudi Arabia</article-title>. <source>Journal of Pure and Applied Microbiology</source>. <year>2014</year>;<volume>8</volume>(<issue>1</issue>):<fpage>225</fpage>&#x02013;<lpage>31</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref095"><label>95</label><mixed-citation publication-type="journal"><name><surname>Al-Azraqi</surname><given-names>TA</given-names></name>, <name><surname>El Mekki</surname><given-names>AA</given-names></name>, <name><surname>Mahfouzc</surname><given-names>AA</given-names></name>. <article-title>Seroprevalence of dengue virus infection in Aseer and Jizan regions, Southwestern Saudi Arabia</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>. <year>2013</year>;<volume>107</volume>(<issue>6</issue>):<fpage>368</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1093/trstmh/trt022</pub-id>
<?supplied-pmid 23474472?><pub-id pub-id-type="pmid">23474472</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref096"><label>96</label><mixed-citation publication-type="journal"><name><surname>Ashshi</surname><given-names>AM</given-names></name>. <article-title>Serodetection of Dengue virus and its antibodies among blood donors in the western region of Saudi Arabia: a preliminary study</article-title>. <source>Blood Transfus</source>. <year>2015</year>;<volume>13</volume>(<issue>1</issue>):<fpage>135</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2450/2014.0134-14</pub-id>
<?supplied-pmid 25369603?><pub-id pub-id-type="pmid">25369603</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref097"><label>97</label><mixed-citation publication-type="journal"><name><surname>Botros</surname><given-names>BAM</given-names></name>, <name><surname>Watts</surname><given-names>DM</given-names></name>, <name><surname>Soliman</surname><given-names>AK</given-names></name>, <name><surname>Salib</surname><given-names>AW</given-names></name>, <name><surname>Moussa</surname><given-names>MI</given-names></name>, <name><surname>Mursal</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Serological evidence of dengue fever among refugees, Hargeysa, Somalia</article-title>. <source>Journal of Medical Virology</source>. <year>1989</year>;<volume>29</volume>(<issue>2</issue>):<fpage>79</fpage>&#x02013;<lpage>81</lpage>. <?supplied-pmid 2600591?><pub-id pub-id-type="pmid">2600591</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref098"><label>98</label><mixed-citation publication-type="journal"><name><surname>Kanesa-thasan</surname><given-names>N</given-names></name>, <name><surname>Iacono-Connors</surname><given-names>L</given-names></name>, <name><surname>Magill</surname><given-names>A</given-names></name>, <name><surname>Smoak</surname><given-names>B</given-names></name>, <name><surname>Vaughn</surname><given-names>D</given-names></name>, <name><surname>Dubois</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Dengue serotypes 2 and 3 in US forces in Somalia</article-title>. <source>Lancet</source>. <year>1994</year>;<volume>343</volume>(<issue>8898</issue>):<fpage>678</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref099"><label>99</label><mixed-citation publication-type="journal"><name><surname>Sharp</surname><given-names>TW</given-names></name>, <name><surname>Wallace</surname><given-names>MR</given-names></name>, <name><surname>Hayes</surname><given-names>CG</given-names></name>, <name><surname>Sanchez</surname><given-names>JL</given-names></name>, <name><surname>DeFraites</surname><given-names>RF</given-names></name>, <name><surname>Arthur</surname><given-names>RR</given-names></name>, <etal>et al</etal>
<article-title>Dengue fever in U.S. troops during Operation Restore Hope, Somalia, 1992&#x02013;1993</article-title>. <source>Am J Trop Med Hyg</source>. <year>1995</year>;<volume>53</volume>(<issue>1</issue>):<fpage>89</fpage>&#x02013;<lpage>94</lpage>. <?supplied-pmid 7625541?><pub-id pub-id-type="pmid">7625541</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref100"><label>100</label><mixed-citation publication-type="journal"><name><surname>Nur</surname><given-names>YA</given-names></name>, <name><surname>Groen</surname><given-names>J</given-names></name>, <name><surname>Yusuf</surname><given-names>MA</given-names></name>, <article-title>Osterhaus ADME. IgM antibodies in hospitalized children with febrile illness during an inter-epidemic period of measles, in Somalia</article-title>. <source>Journal of Clinical Virology</source>. <year>1999</year>;<volume>12</volume>(<issue>1</issue>):<fpage>21</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 10073410?><pub-id pub-id-type="pmid">10073410</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref101"><label>101</label><mixed-citation publication-type="journal"><name><surname>Kyobe Bosa</surname><given-names>H</given-names></name>, <name><surname>Montgomery</surname><given-names>JM</given-names></name>, <name><surname>Kimuli</surname><given-names>I</given-names></name>, <name><surname>Lutwama</surname><given-names>JJ</given-names></name>. <article-title>Dengue fever outbreak in Mogadishu, Somalia 2011: Co-circulation of three dengue virus serotypes</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2014</year>;<volume>21</volume>:<fpage>3</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref102"><label>102</label><mixed-citation publication-type="journal"><name><surname>Hyams</surname><given-names>KC</given-names></name>, <name><surname>Oldfield</surname><given-names>EC</given-names></name>, <name><surname>McNair Scott</surname><given-names>R</given-names></name>. <article-title>Evaluation of febrile patients in Port Sudan, Sudan: Isolation of dengue virus</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. <year>1986</year>;<volume>35</volume>(<issue>4</issue>):<fpage>860</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 3728800?><pub-id pub-id-type="pmid">3728800</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref103"><label>103</label><mixed-citation publication-type="journal"><name><surname>Woodruff</surname><given-names>PWR</given-names></name>, <name><surname>Morrill</surname><given-names>JC</given-names></name>, <name><surname>Burans</surname><given-names>JP</given-names></name>, <name><surname>Hyams</surname><given-names>KC</given-names></name>, <name><surname>Woody</surname><given-names>JN</given-names></name>. <article-title>A study of viral and rickettsial exposure and causes of fever in Juba, southern Sudan</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>. <year>1988</year>;<volume>82</volume>(<issue>5</issue>):<fpage>761</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 2855284?><pub-id pub-id-type="pmid">2855284</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref104"><label>104</label><mixed-citation publication-type="journal"><name><surname>McCarthy</surname><given-names>MC</given-names></name>, <name><surname>Haberberger</surname><given-names>RL</given-names></name>, <name><surname>Salib</surname><given-names>AW</given-names></name>, <name><surname>Soliman</surname><given-names>BA</given-names></name>, <name><surname>El-Tigani</surname><given-names>A</given-names></name>, <name><surname>Khalid</surname><given-names>IO</given-names></name>, <etal>et al</etal>
<article-title>Evaluation of arthropod-borne viruses and other infectious disease pathogens as the causes of febrile illnesses in the Khartoum province of Sudan</article-title>. <source>Journal of Medical Virology</source>. <year>1996</year>;<volume>48</volume>(<issue>2</issue>):<fpage>141</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(199602)48:2&#x0003c;141::AID-JMV4&#x0003e;3.0.CO;2-9</pub-id>
<?supplied-pmid 8835346?><pub-id pub-id-type="pmid">8835346</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref105"><label>105</label><mixed-citation publication-type="journal"><name><surname>Ibrahim</surname><given-names>SA</given-names></name>, <name><surname>Mustafa</surname><given-names>OM</given-names></name>, <name><surname>Mukhtar</surname><given-names>MM</given-names></name>, <name><surname>Saleh</surname><given-names>EA</given-names></name>, <name><surname>El Mubarak</surname><given-names>HS</given-names></name>, <name><surname>Abdallah</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Measles in suburban Khartoum: An epidemiological and clinical study</article-title>. <source>Tropical Medicine and International Health</source>. <year>2002</year>;<volume>7</volume>(<issue>5</issue>):<fpage>442</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 12000654?><pub-id pub-id-type="pmid">12000654</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref106"><label>106</label><mixed-citation publication-type="journal"><name><surname>Malik</surname><given-names>A</given-names></name>, <name><surname>Earhart</surname><given-names>K</given-names></name>, <name><surname>Mohareb</surname><given-names>E</given-names></name>, <name><surname>Saad</surname><given-names>M</given-names></name>, <name><surname>Saeed</surname><given-names>M</given-names></name>, <name><surname>Ageep</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Dengue hemorrhagic fever outbreak in children in Port Sudan</article-title>. <source>Journal of Infection and Public Health</source>. <year>2011</year>;<volume>4</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jiph.2010.08.001</pub-id>
<?supplied-pmid 21338953?><pub-id pub-id-type="pmid">21338953</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref107"><label>107</label><mixed-citation publication-type="journal"><name><surname>Gould</surname><given-names>LH</given-names></name>, <name><surname>Osman</surname><given-names>MS</given-names></name>, <name><surname>Farnon</surname><given-names>EC</given-names></name>, <name><surname>Griffith</surname><given-names>KS</given-names></name>, <name><surname>Godsey</surname><given-names>MS</given-names></name>, <name><surname>Karch</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>An outbreak of yellow fever with concurrent chikungunya virus transmission in South Kordofan, Sudan, 2005</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>. <year>2008</year>;<volume>102</volume>(<issue>12</issue>):<fpage>1247</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.trstmh.2008.04.014</pub-id>
<?supplied-pmid 18502458?><pub-id pub-id-type="pmid">18502458</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref108"><label>108</label><mixed-citation publication-type="journal"><name><surname>Adam</surname><given-names>I</given-names></name>, <name><surname>Jumaa</surname><given-names>AM</given-names></name>, <name><surname>Elbashir</surname><given-names>HM</given-names></name>, <name><surname>Karsany</surname><given-names>MS</given-names></name>. <article-title>Maternal and perinatal outcomes of dengue in PortSudan, Eastern Sudan</article-title>. <source>Virology Journal</source>. <year>2010</year>;<volume>7</volume>(<issue>153</issue>).</mixed-citation></ref><ref id="pntd.0005194.ref109"><label>109</label><mixed-citation publication-type="journal"><name><surname>Himatt</surname><given-names>S</given-names></name>, <name><surname>Osman</surname><given-names>KE</given-names></name>, <name><surname>Okoued</surname><given-names>SI</given-names></name>, <name><surname>Seidahmed</surname><given-names>OE</given-names></name>, <name><surname>Beatty</surname><given-names>ME</given-names></name>, <name><surname>Soghaier</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>Sero-prevalence of dengue infections in the Kassala state in the eastern part of the Sudan in 2011</article-title>. <source>J Infect Public Health</source>. <year>2015</year>.</mixed-citation></ref><ref id="pntd.0005194.ref110"><label>110</label><mixed-citation publication-type="journal"><name><surname>Abdalla</surname><given-names>TM</given-names></name>, <name><surname>Karsany</surname><given-names>MS</given-names></name>, <name><surname>Ali</surname><given-names>AA</given-names></name>. <article-title>Correlation of measles and dengue infection in Kassala, Eastern Sudan</article-title>. <source>J Med Virol</source>. <year>2014</year>.</mixed-citation></ref><ref id="pntd.0005194.ref111"><label>111</label><mixed-citation publication-type="journal"><name><surname>Soghaier</surname><given-names>MA</given-names></name>, <name><surname>Mahmood</surname><given-names>SF</given-names></name>, <name><surname>Pasha</surname><given-names>O</given-names></name>, <name><surname>Azam</surname><given-names>SI</given-names></name>, <name><surname>Karsani</surname><given-names>MM</given-names></name>, <name><surname>Elmangory</surname><given-names>MM</given-names></name>, <etal>et al</etal>
<article-title>Factors associated with dengue fever IgG sero-prevalence in South Kordofan State, Sudan, in 2012: Reporting prevalence ratios</article-title>. <source>Journal of Infection and Public Health</source>. <year>2014</year>;<volume>7</volume>(<issue>1</issue>):<fpage>54</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.jiph.2013.07.008</pub-id>
<?supplied-pmid 24210245?><pub-id pub-id-type="pmid">24210245</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref112"><label>112</label><mixed-citation publication-type="journal"><name><surname>Radda</surname><given-names>A</given-names></name>. <article-title>Studies on the activity and ecology of arboviruses in Turkey</article-title>. <source>ZblBaktReihe A</source>. <year>1973</year>;<volume>225</volume>(<issue>1</issue>):<fpage>19</fpage>&#x02013;<lpage>26</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref113"><label>113</label><mixed-citation publication-type="journal"><name><surname>Ergunay</surname><given-names>K</given-names></name>, <name><surname>Saygan</surname><given-names>MB</given-names></name>, <name><surname>Aydogan</surname><given-names>S</given-names></name>, <name><surname>Litzba</surname><given-names>N</given-names></name>, <name><surname>Niedrig</surname><given-names>M</given-names></name>, <name><surname>Pinar</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Investigation of dengue virus and yellow fever virus seropositivities in blood donors from central/Northern Anatolia, Turkey</article-title>. <source>Mikrobiyoloji Bulteni</source>. <year>2010</year>;<volume>44</volume>(<issue>3</issue>):<fpage>415</fpage>&#x02013;<lpage>24</lpage>. <?supplied-pmid 21063991?><pub-id pub-id-type="pmid">21063991</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref114"><label>114</label><mixed-citation publication-type="journal"><name><surname>Tezcan</surname><given-names>S</given-names></name>, <name><surname>Kizildamar</surname><given-names>S</given-names></name>, <name><surname>Ulger</surname><given-names>M</given-names></name>, <name><surname>Aslan</surname><given-names>G</given-names></name>, <name><surname>Tiftik</surname><given-names>N</given-names></name>, <name><surname>Ozkul</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Flavivirus seroepidemiology in blood donors in Mersin province, Turkey</article-title>. <source>Mikrobiyoloji bulteni</source>. <year>2014</year>;<volume>48</volume>(<issue>4</issue>):<fpage>606</fpage>&#x02013;<lpage>17</lpage>. <?supplied-pmid 25492656?><pub-id pub-id-type="pmid">25492656</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref115"><label>115</label><mixed-citation publication-type="journal"><name><surname>Bin Ghouth</surname><given-names>AS</given-names></name>, <name><surname>Amarasinghe</surname><given-names>A</given-names></name>, <name><surname>Letson</surname><given-names>GW</given-names></name>. <article-title>Dengue outbreak in Hadramout, Yemen, 2010: an epidemiological perspective</article-title>. <source>Am J Trop Med Hyg</source>. <year>2012</year>;<volume>86</volume>(<issue>6</issue>):<fpage>1072</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2012.11-0723</pub-id>
<?supplied-pmid 22665621?><pub-id pub-id-type="pmid">22665621</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref116"><label>116</label><mixed-citation publication-type="journal"><name><surname>Malik</surname><given-names>MR</given-names></name>, <name><surname>Mnzava</surname><given-names>A</given-names></name>, <name><surname>Mohareb</surname><given-names>E</given-names></name>, <name><surname>Zayed</surname><given-names>A</given-names></name>, <name><surname>Al Kohlani</surname><given-names>A</given-names></name>, <name><surname>Thabet</surname><given-names>AAK</given-names></name>, <etal>et al</etal>
<article-title>Chikungunya outbreak in Al-Hudaydah, Yemen, 2011: Epidemiological characterization and key lessons learned for early detection and control</article-title>. <source>Journal of Epidemiology and Global Health</source>. <year>2014</year>;<volume>4</volume>(<issue>3</issue>):<fpage>203</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.jegh.2014.01.004</pub-id>
<?supplied-pmid 25107656?><pub-id pub-id-type="pmid">25107656</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref117"><label>117</label><mixed-citation publication-type="journal"><name><surname>Madani</surname><given-names>TA</given-names></name>, <name><surname>Abuelzein</surname><given-names>ETME</given-names></name>, <name><surname>Al-Bar</surname><given-names>HMS</given-names></name>, <name><surname>Azhar</surname><given-names>EI</given-names></name>, <name><surname>Kao</surname><given-names>M</given-names></name>, <name><surname>Alshoeb</surname><given-names>HO</given-names></name>, <etal>et al</etal>
<article-title>Outbreak of viral hemorrhagic fever caused by dengue virus type 3 in Al-Mukalla, Yemen</article-title>. <source>BMC Infectious Diseases</source>. <year>2013</year>;<volume>13</volume>(<issue>1</issue>).</mixed-citation></ref><ref id="pntd.0005194.ref118"><label>118</label><mixed-citation publication-type="journal"><name><surname>Rezza</surname><given-names>G</given-names></name>, <name><surname>El-Sawaf</surname><given-names>G</given-names></name>, <name><surname>Faggioni</surname><given-names>G</given-names></name>, <name><surname>Vescio</surname><given-names>F</given-names></name>, <name><surname>Al Ameri</surname><given-names>R</given-names></name>, <name><surname>De Santis</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Co-circulation of Dengue and Chikungunya Viruses, Al Hudaydah, Yemen, 2012</article-title>. <source>Emerg Infect Dis</source>. <year>2014</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1351</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3201/eid2008.131615</pub-id>
<?supplied-pmid 25061762?><pub-id pub-id-type="pmid">25061762</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref119"><label>119</label><mixed-citation publication-type="journal"><name><surname>Qassem</surname><given-names>MAM</given-names></name>, <name><surname>Jaawal</surname><given-names>AAT</given-names></name>. <article-title>Dengue fever or West Nile virus outbreak? Yemen 2013</article-title>. <source>International Journal of Infectious Diseases</source>. <year>2014</year>;<volume>21</volume>:<fpage>457</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref120"><label>120</label><mixed-citation publication-type="journal"><collab>World Health Organizationj Regional Office for the Eastern Mediterranean</collab>. <article-title>Dengue in Pakistan</article-title>. <source>Weekly Epidemiological Monitor</source>. <year>2013</year>;<volume>6</volume>(<issue>52</issue>). Available <ext-link ext-link-type="uri" xlink:href="http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/">www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/</ext-link>. Accessed 17 Jan 2016.</mixed-citation></ref><ref id="pntd.0005194.ref121"><label>121</label><mixed-citation publication-type="journal"><name><surname>Haider</surname><given-names>Z</given-names></name>, <name><surname>Ahmad</surname><given-names>FZ</given-names></name>, <name><surname>Mahmood</surname><given-names>A</given-names></name>, <name><surname>Waseem</surname><given-names>T</given-names></name>, <name><surname>Shafiq</surname><given-names>I</given-names></name>, <name><surname>Raza</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Dengue fever in Pakistan: A paradigm shift; Changing epidemiology and clinical patterns</article-title>. <source>Perspectives in Public Health</source>. <year>2015</year>;<volume>135</volume>(<issue>6</issue>):<fpage>294</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1177/1757913915599019</pub-id>
<?supplied-pmid 26342006?><pub-id pub-id-type="pmid">26342006</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref122"><label>122</label><mixed-citation publication-type="journal"><name><surname>Weaver</surname><given-names>SC</given-names></name>, <name><surname>Lecuit</surname><given-names>M</given-names></name>. <article-title>Chikungunya virus and the global spread of a mosquito-borne disease</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>372</volume>(<issue>13</issue>):<fpage>1231</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1406035</pub-id>
<?supplied-pmid 25806915?><pub-id pub-id-type="pmid">25806915</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref123"><label>123</label><mixed-citation publication-type="journal"><name><surname>Nsoesie</surname><given-names>EO</given-names></name>, <name><surname>Kraemer</surname><given-names>MU</given-names></name>, <name><surname>Golding</surname><given-names>N</given-names></name>, <name><surname>Pigott</surname><given-names>DM</given-names></name>, <name><surname>Brady</surname><given-names>OJ</given-names></name>, <name><surname>Moyes</surname><given-names>CL</given-names></name>, <etal>et al</etal>
<article-title>Global Distribution and Environmental Suitability for Chikungunya Virus, 1952&#x02013;2015</article-title>. <source>Euro Surveillance</source>. <year>2016</year>;<volume>21</volume>(<issue>20</issue>):pii = 30234.</mixed-citation></ref><ref id="pntd.0005194.ref124"><label>124</label><mixed-citation publication-type="journal"><name><surname>Koo</surname><given-names>C</given-names></name>, <name><surname>Nasir</surname><given-names>A</given-names></name>, <name><surname>Hapuarachchi</surname><given-names>HC</given-names></name>, <name><surname>Lee</surname><given-names>KS</given-names></name>, <name><surname>Hasan</surname><given-names>Z</given-names></name>, <name><surname>Ng</surname><given-names>LC</given-names></name>, <etal>et al</etal>
<article-title>Evolution and heterogeneity of multiple serotypes of Dengue virus in Pakistan, 2006&#x02013;2011</article-title>. <source>Virol J</source>. <year>2013</year>;<volume>10</volume>:<fpage>275</fpage>
<pub-id pub-id-type="doi">10.1186/1743-422X-10-275</pub-id>
<?supplied-pmid 24007412?><pub-id pub-id-type="pmid">24007412</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref125"><label>125</label><mixed-citation publication-type="journal"><name><surname>Jimenez-Lucho</surname><given-names>VE</given-names></name>, <name><surname>Fisher</surname><given-names>EJ</given-names></name>, <name><surname>Saravolatz</surname><given-names>LD</given-names></name>. <article-title>Dengue with hemorrhagic manifestations: An imported case from the Middle East</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. <year>1984</year>;<volume>33</volume>(<issue>4</issue>):<fpage>650</fpage>&#x02013;<lpage>3</lpage>. <?supplied-pmid 6476211?><pub-id pub-id-type="pmid">6476211</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref126"><label>126</label><mixed-citation publication-type="other">World Health Organization. Dengue: Guidelines for Diagnosis, Treatement, Prevention and Control. Geneva, Switzerland. 2009. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf">http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf</ext-link> Accessed 1 September 2016.</mixed-citation></ref><ref id="pntd.0005194.ref127"><label>127</label><mixed-citation publication-type="journal"><collab>World Health Organization Regional Office for the Eastern Mediterranean</collab>. <article-title>Multiple outbreaks from DF/DHF in the EMR</article-title>. <year>2008</year>;<volume>1</volume>(<issue>30</issue>). Available <ext-link ext-link-type="uri" xlink:href="http://www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/">www.emro.who.int/surveillance-forecasting-response/weekly-epidemiological-monitor/</ext-link>. Accessed 17 Jan 2016.</mixed-citation></ref><ref id="pntd.0005194.ref128"><label>128</label><mixed-citation publication-type="journal"><name><surname>Ghouth</surname><given-names>ASB</given-names></name>, <name><surname>Amarasinghe</surname><given-names>A</given-names></name>, <name><surname>Letson</surname><given-names>GW</given-names></name>. <article-title>Dengue outbreak in Hadramout, Yemen, 2010: An epidemiological perspective</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. 1072;<volume>86</volume>(<issue>6</issue>):<fpage>1072</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.4269/ajtmh.2012.11-0723</pub-id>
<?supplied-pmid 22665621?><pub-id pub-id-type="pmid">22665621</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref129"><label>129</label><mixed-citation publication-type="journal"><name><surname>Burdino</surname><given-names>E</given-names></name>, <name><surname>Milia</surname><given-names>MG</given-names></name>, <name><surname>Sergi</surname><given-names>G</given-names></name>, <name><surname>Gregori</surname><given-names>G</given-names></name>, <name><surname>Allice</surname><given-names>T</given-names></name>, <name><surname>Cazzato</surname><given-names>ML</given-names></name>, <etal>et al</etal>
<article-title>Diagnosis of dengue fever in North West Italy in travelers from endemic areas: a retrospective study</article-title>. <source>J Clin Virol</source>. <year>2011</year>;<volume>51</volume>(<issue>4</issue>):<fpage>259</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2011.05.011</pub-id>
<?supplied-pmid 21636317?><pub-id pub-id-type="pmid">21636317</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref130"><label>130</label><mixed-citation publication-type="journal"><name><surname>Heikal</surname><given-names>OM</given-names></name>, <name><surname>El-Bahnasawy</surname><given-names>MM</given-names></name>, <name><surname>Morsy</surname><given-names>AT</given-names></name>, <name><surname>Khalil</surname><given-names>HH</given-names></name>. <article-title>Aedes aegypti re-emerging in Egypt: a review and what should be done?</article-title>
<source>Journal of the Egyptian Society of Parasitology</source>. <year>2011</year>;<volume>41</volume>(<issue>3</issue>):<fpage>801</fpage>&#x02013;<lpage>14</lpage>. <?supplied-pmid 22435171?><pub-id pub-id-type="pmid">22435171</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref131"><label>131</label><mixed-citation publication-type="journal"><name><surname>Ahmadnejad</surname><given-names>F</given-names></name>, <name><surname>Otarod</surname><given-names>V</given-names></name>, <name><surname>Fallah</surname><given-names>MH</given-names></name>, <name><surname>Lowenski</surname><given-names>S</given-names></name>, <name><surname>Sedighi-Moghaddam</surname><given-names>R</given-names></name>, <name><surname>Zavareh</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Spread of West Nile virus in Iran: A cross-sectional serosurvey in equines, 2008&#x02013;2009</article-title>. <source>Epidemiology and Infection</source>. <year>2011</year>;<volume>139</volume>(<issue>10</issue>):<fpage>1587</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1017/S0950268811000173</pub-id>
<?supplied-pmid 21396143?><pub-id pub-id-type="pmid">21396143</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref132"><label>132</label><mixed-citation publication-type="journal"><name><surname>Conley</surname><given-names>AK</given-names></name>, <name><surname>Fuller</surname><given-names>DO</given-names></name>, <name><surname>Haddad</surname><given-names>N</given-names></name>, <name><surname>Hassan</surname><given-names>AN</given-names></name>, <name><surname>Gad</surname><given-names>AM</given-names></name>, <name><surname>Beier</surname><given-names>JC</given-names></name>. <article-title>Modeling the distribution of the West Nile and Rift Valley Fever vector Culex pipiens in arid and semi-arid regions of the Middle East and North Africa</article-title>. <source>Parasites &#x00026; vectors</source>. <year>2014</year>;<volume>7</volume>:<fpage>289</fpage>.<pub-id pub-id-type="pmid">24962735</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref133"><label>133</label><mixed-citation publication-type="journal"><name><surname>Weaver</surname><given-names>SC</given-names></name>, <name><surname>Reisen</surname><given-names>WK</given-names></name>. <article-title>Present and future arboviral threats</article-title>. <source>Antiviral Res</source>. <year>2010</year>;<volume>85</volume>(<issue>2</issue>):<fpage>328</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2009.10.008</pub-id>
<?supplied-pmid 19857523?><pub-id pub-id-type="pmid">19857523</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref134"><label>134</label><mixed-citation publication-type="journal"><name><surname>Rabe</surname><given-names>IB</given-names></name>, <name><surname>Staples</surname><given-names>JE</given-names></name>, <name><surname>Villanueva</surname><given-names>J</given-names></name>, <name><surname>Hummel</surname><given-names>KB</given-names></name>, <name><surname>Johnson</surname><given-names>JA</given-names></name>, <name><surname>Rose</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Interim Guidance for Interpretation of Zika Virus Antibody Test Results</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2016</year>;<volume>65</volume>(<issue>21</issue>):<fpage>543</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6521e1</pub-id>
<?supplied-pmid 27254248?><pub-id pub-id-type="pmid">27254248</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref135"><label>135</label><mixed-citation publication-type="journal"><name><surname>Kraemer</surname><given-names>MU</given-names></name>, <name><surname>Sinka</surname><given-names>ME</given-names></name>, <name><surname>Duda</surname><given-names>KA</given-names></name>, <name><surname>Mylne</surname><given-names>AQ</given-names></name>, <name><surname>Shearer</surname><given-names>FM</given-names></name>, <name><surname>Barker</surname><given-names>CM</given-names></name>, <etal>et al</etal>
<article-title>The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus</article-title>. <source>Elife</source>. <year>2015</year>;<volume>4</volume>:<fpage>e08347</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.08347</pub-id>
<?supplied-pmid 26126267?><pub-id pub-id-type="pmid">26126267</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref136"><label>136</label><mixed-citation publication-type="journal"><name><surname>Izri</surname><given-names>A</given-names></name>, <name><surname>Bitam</surname><given-names>I</given-names></name>, <name><surname>Charrel</surname><given-names>RN</given-names></name>. <article-title>First entomological documentation of Aedes (Stegomyia) albopictus (Skuse, 1894) in Algeria</article-title>. <source>Clinical Microbiology and Infection</source>. 1116;<volume>17</volume>(<issue>7</issue>):<fpage>1116</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03443.x</pub-id>
<?supplied-pmid 21435096?><pub-id pub-id-type="pmid">21435096</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref137"><label>137</label><mixed-citation publication-type="journal"><name><surname>Haddad</surname><given-names>N</given-names></name>, <name><surname>Harbach</surname><given-names>RE</given-names></name>, <name><surname>Chamat</surname><given-names>S</given-names></name>, <name><surname>Bouharoun-Tayoun</surname><given-names>H</given-names></name>. <article-title>Presence of Aedes albopictus in Lebanon and Syria</article-title>. <source>J Am Mosq Control Assoc</source>. <year>2007</year>;<volume>23</volume>(<issue>2</issue>):<fpage>226</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2987/8756-971X(2007)23[226:POAAIL]2.0.CO;2</pub-id>
<?supplied-pmid 17847859?><pub-id pub-id-type="pmid">17847859</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref138"><label>138</label><mixed-citation publication-type="journal"><name><surname>Adawi</surname><given-names>SHAA</given-names></name>. <article-title>Presence of Aedes albopictus in Palestine&#x02013;West Bank</article-title>. <source>International Journal of Tropical Disease and Health</source>. <year>2012</year>;<volume>2</volume>(<issue>4</issue>):<fpage>301</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref139"><label>139</label><mixed-citation publication-type="journal"><name><surname>Leshem</surname><given-names>E</given-names></name>, <name><surname>Bin</surname><given-names>H</given-names></name>, <name><surname>Shalom</surname><given-names>U</given-names></name>, <name><surname>Perkin</surname><given-names>M</given-names></name>, <name><surname>Schwartz</surname><given-names>E</given-names></name>. <article-title>Risk for emergence of dengue and chikungunya virus in Israel</article-title>. <source>Emerging Infectious Diseases</source>. <year>2012</year>;<volume>18</volume>(<issue>2</issue>):<fpage>345</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3201/eid1802.111648</pub-id>
<?supplied-pmid 22305194?><pub-id pub-id-type="pmid">22305194</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref140"><label>140</label><mixed-citation publication-type="journal"><name><surname>Oter</surname><given-names>K</given-names></name>, <name><surname>Gunay</surname><given-names>F</given-names></name>, <name><surname>Tuzer</surname><given-names>E</given-names></name>, <name><surname>Linton</surname><given-names>YM</given-names></name>, <name><surname>Bellini</surname><given-names>R</given-names></name>, <name><surname>Alten</surname><given-names>B</given-names></name>. <article-title>First record of Stegomyia albopicta in Turkey determined by active ovitrap surveillance and DNA barcoding</article-title>. <source>Vector Borne Zoonotic Dis</source>. <year>2013</year>;<volume>13</volume>(<issue>10</issue>):<fpage>753</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1089/vbz.2012.1093</pub-id>
<?supplied-pmid 23808976?><pub-id pub-id-type="pmid">23808976</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref141"><label>141</label><mixed-citation publication-type="book"><collab>European Centre for Disease Prevention and Control</collab>. <chapter-title>Guidelines for the surveillance of invasive mosquitoes in Europe</chapter-title>
<publisher-loc>Stockholm</publisher-loc>: <publisher-name>ECDC</publisher-name>; <year>2012</year> Available at: <ext-link ext-link-type="uri" xlink:href="http://ecdc.europa.eu/en/publications/publications/ter-mosquito-surveillance-guidelines.pdf">http://ecdc.europa.eu/en/publications/publications/ter-mosquito-surveillance-guidelines.pdf</ext-link>. Accessed 15 Jan 2016.</mixed-citation></ref><ref id="pntd.0005194.ref142"><label>142</label><mixed-citation publication-type="other">The World Bank Group. The Middle East and North Africa: Urban Development 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://go.worldbank.org/Y88FI6V7R0">http://go.worldbank.org/Y88FI6V7R0</ext-link>. Accessed 8 Feb 2016.</mixed-citation></ref><ref id="pntd.0005194.ref143"><label>143</label><mixed-citation publication-type="journal"><name><surname>Soghaier</surname><given-names>MA</given-names></name>, <name><surname>Hagar</surname><given-names>A</given-names></name>, <name><surname>Abbas</surname><given-names>MA</given-names></name>, <name><surname>Elmangory</surname><given-names>MM</given-names></name>, <name><surname>Eltahir</surname><given-names>KM</given-names></name>, <name><surname>Sall</surname><given-names>AA</given-names></name>. <article-title>Yellow fever outbreak in Darfur, Sudan in october 2012; the initial outbreak investigation report</article-title>. <source>Journal of Infection and Public Health</source>. <year>2013</year>;<volume>6</volume>(<issue>5</issue>):<fpage>370</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.jiph.2013.04.007</pub-id>
<?supplied-pmid 23999341?><pub-id pub-id-type="pmid">23999341</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref144"><label>144</label><mixed-citation publication-type="journal"><name><surname>Seidahmed</surname><given-names>O</given-names></name>, <name><surname>Siam</surname><given-names>HA</given-names></name>, <name><surname>Hassan</surname><given-names>SA</given-names></name>, <name><surname>Mohamed</surname><given-names>SA</given-names></name>, <name><surname>Abd Elrhman</surname><given-names>LS</given-names></name>, <name><surname>Osman</surname><given-names>HA</given-names></name>, <etal>et al</etal>
<article-title>Vector control and surveillance during a major outbreak of dengue in a coastal Red Sea area: Port Sudan City</article-title>. <source>American Journal of Tropical Medicine and Hygiene</source>. <year>2011</year>;<issue>1</issue>):<fpage>92</fpage>.</mixed-citation></ref><ref id="pntd.0005194.ref145"><label>145</label><mixed-citation publication-type="journal"><name><surname>Gould</surname><given-names>EA</given-names></name>, <name><surname>Higgs</surname><given-names>S</given-names></name>. <article-title>Impact of climate change and other factors on emerging arbovirus diseases</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>2009</year>;<volume>103</volume>(<issue>2</issue>):<fpage>109</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.trstmh.2008.07.025</pub-id>
<?supplied-pmid 18799177?><pub-id pub-id-type="pmid">18799177</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref146"><label>146</label><mixed-citation publication-type="journal"><name><surname>Amarasinghe</surname><given-names>A</given-names></name>, <name><surname>Letson</surname><given-names>GW</given-names></name>. <article-title>Dengue in the Middle East: A neglected, emerging disease of importance</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>. <year>2012</year>;<volume>106</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/j.trstmh.2011.08.014</pub-id>
<?supplied-pmid 22137535?><pub-id pub-id-type="pmid">22137535</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref147"><label>147</label><mixed-citation publication-type="journal"><name><surname>Fahmy</surname><given-names>NT</given-names></name>, <name><surname>Klena</surname><given-names>JD</given-names></name>, <name><surname>Mohamed</surname><given-names>AS</given-names></name>, <name><surname>Zayed</surname><given-names>A</given-names></name>, <name><surname>Villinski</surname><given-names>JT</given-names></name>. <article-title>Complete Genome Sequence of Chikungunya Virus Isolated from an Aedes aegypti Mosquito during an Outbreak in Yemen, 2011</article-title>. <source>Genome announcements</source>. <year>2015</year>;<volume>3</volume>(<issue>4</issue>).</mixed-citation></ref><ref id="pntd.0005194.ref148"><label>148</label><mixed-citation publication-type="journal"><name><surname>Ciccozzi</surname><given-names>M</given-names></name>, <name><surname>Lo Presti</surname><given-names>A</given-names></name>, <name><surname>Cella</surname><given-names>E</given-names></name>, <name><surname>Giovanetti</surname><given-names>M</given-names></name>, <name><surname>Lai</surname><given-names>A</given-names></name>, <name><surname>El-Sawaf</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Phylogeny of Dengue and Chikungunya viruses in Al Hudayda governorate, Yemen</article-title>. <source>Infection, genetics and evolution: Journal of molecular epidemiology and evolutionary genetics in infectious diseases</source>. <year>2014</year>;<volume>27C</volume>:<fpage>395</fpage>&#x02013;<lpage>401</lpage>.</mixed-citation></ref><ref id="pntd.0005194.ref149"><label>149</label><mixed-citation publication-type="journal"><name><surname>Rezza</surname><given-names>G</given-names></name>, <name><surname>El-Sawaf</surname><given-names>G</given-names></name>, <name><surname>Faggioni</surname><given-names>G</given-names></name>, <name><surname>Vescio</surname><given-names>F</given-names></name>, <name><surname>Al Ameri</surname><given-names>R</given-names></name>, <name><surname>De Santis</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Co-circulation of dengue and chikungunya viruses, Al Hudaydah, Yemen, 2012</article-title>. <source>Emerging Infectious Diseases</source>. <year>2014</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1351</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3201/eid2008.131615</pub-id>
<?supplied-pmid 25061762?><pub-id pub-id-type="pmid">25061762</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref150"><label>150</label><mixed-citation publication-type="journal"><name><surname>Awaidy</surname><given-names>ST</given-names></name>, <name><surname>Obeidani</surname><given-names>IA</given-names></name>, <name><surname>Bawikar</surname><given-names>S</given-names></name>, <name><surname>Mahrouqi</surname><given-names>SA</given-names></name>, <name><surname>Busaidy</surname><given-names>SS</given-names></name>, <name><surname>Baqlani</surname><given-names>SA</given-names></name>, <etal>et al</etal>
<article-title>Dengue epidemiological trend in Oman: a 13-year national surveillance and strategic proposition of imported cases</article-title>. <source>Trop Doct</source>. <year>2014</year>.</mixed-citation></ref><ref id="pntd.0005194.ref151"><label>151</label><mixed-citation publication-type="journal"><name><surname>Cleton</surname><given-names>NB</given-names></name>, <name><surname>Godeke</surname><given-names>GJ</given-names></name>, <name><surname>Reimerink</surname><given-names>J</given-names></name>, <name><surname>Beersma</surname><given-names>MF</given-names></name>, <name><surname>Doorn</surname><given-names>HR</given-names></name>, <name><surname>Franco</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Spot the difference-development of a syndrome based protein microarray for specific serological detection of multiple flavivirus infections in travelers</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2015</year>;<volume>9</volume>(<issue>3</issue>):<fpage>e0003580</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pntd.0003580</pub-id>
<?supplied-pmid 25767876?><pub-id pub-id-type="pmid">25767876</pub-id></mixed-citation></ref><ref id="pntd.0005194.ref152"><label>152</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention. Mosquito Surveillance Software. Atlanta, GA, USA 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/westnile/resourcepages/mosqsurvsoft.html">http://www.cdc.gov/westnile/resourcepages/mosqsurvsoft.html</ext-link>. Accessed 8 Feb 2016.</mixed-citation></ref></ref-list></back></article>